0001080657 presidio property trust --12-31 Q3 2024 0.01 0.01 1,000,000 1,000,000 1,000,000 1,000,000 25.00 25.00 890,946 890,946 0.01 0.01 100,000,000 100,000,000 12,369,645 12,369,645 12,265,061 12,265,061 2 2 10 4,382 13,145 1 5 1 0 0.2 0.7 0 0 0.7 2 1 5 4 1 1 1 92.0 0 0 5 5 2 1 2 66.67 1 5 5 0 92.0 0 0 2 3 10 1 4 149,253 3 346,762 包括土地、建築物及改善、現金、現金等價物及限制性現金、當前應收款項、遞延租金應收款項和遞延租賃成本及其他相關的無形資產,均以淨額顯示。 包括與房產收購相關的租賃無形資產及土地購買選項。 達科塔中心物業的非追索貸款於2024年7月6日到期。在2024年10月,管理層已與貸款方達成一致,將該物業出售以清償貸款餘額。由於法戈市場的不確定性,我們已減值該物業的帳面價值並於2024年9月30日記錄了約70萬美元的減值損失。 這些抵押貸款在未來十二個月內到期,管理層正在審查各種貸款到期的選擇,包括但不限於再融資、重組及或出售這些房產。隨著我們逐漸接近貸款到期日,公司將最終確定我們的計劃。 包括截至2024年9月30日及2023年12月31日列為待售的樣板房。在截至2024年9月30日的三個及九個月內,我們為樣板房記錄了減值損失,分別為41,656美元及238,449美元,這反映了2024年每個季度結束後這些特定樣板房的估計銷售價格。持有期短於兩年,以及我們購買房屋後建築商更改其模型風格,導致銷售價格低於預期。 截至2024年6月30日的利率期貨。 在2024年6月20日,公司通過其子公司對我們在西法戈的工業物業進行了抵押貸款再融資,並簽訂了一項約575萬美元的貸款協議,期限為五年,利率為7.14%。該貸款協議的債務服務覆蓋率("DSCR")最低為1.20比1.00,由貸款方計算,其中:(a) 分子為承保淨現金流;(b) 分母為年度債務服務,於每個財政季度結束時進行測試。 在截至2023年12月31日的年度內,我們記錄了200萬美元的減值損失,涉及一個公園中心,這反映了管理層基於在同一地理區域內類似房產的銷售可比物業以及未來現金流或已執行的購買銷售協議的公允市價的修訂估計。在截至2024年9月30日的九個月內,未認為需要額外的減值。 從高地法院售出所得的部分收入,用於根據《法典》第1031條進行的同類物業交換交易,以取得我們的曼多林物業。曼多林由NetREIt Palm Self-Storage LP擁有,通過其全資子公司NetREIt Highland LLC,而該公司是唯一的普通合夥人,擁有NetREIt Palm Self-Storage LP的61.3%。 創世廣場由兩個共同租戶擁有,分別是NetREIt Genesis和NetREIt Genessis II,各自擁有57%和43%。根據我們對每個實體的擁有權,我們實際擁有92.0%的股份。我們擁有NetREIt Genesis的100%所有權,擁有NetREIt Genesis II的81.5%所有權,並且我們控制這兩個實體。在2024年7月,公司因NetREIt Genesis II內一個非控制信託的死亡,完成了少數股權轉換選項。根據最初的交換協議,公司以其在NetREIt Genesis II中的36.4%的所有權,向該信託發行了78,215股SQFt A系列普通股。 達科塔中心的貸款將於2024年7月6日到期。管理層一直在與貸款的特殊服務商進行談判,修改和/或延長貸款,或者可能出售該建築。截至2024年8月12日,公司與貸款方尚未就最終結果達成一致。預計貸款方將於8月底訪問該物業。 在2023年5月5日,公司通過其子公司,對我們的Grand Pacific Center物業進行了抵押貸款的再融資,並進入了一項與KLJ Engineering LLC租約相關的施工貸款,該租約佔用該大樓的33,296平方英尺。再融資的貸款約為380萬美元,期限為10年,前60個月的利率為6.35%。利率將在第五年重置。施工貸款約為270萬美元,期限為10年,並將在第三年開始攤還,前60個月的利率為6.35%。利率將在第五年重置。截至2024年6月30日,我們已經提取了約260萬美元的施工貸款。 截至2024年9月30日,聯盟城中心和研究公園已列為出售,並包含在截至2024年9月30日的已持有待售房地產資產淨額中。我們預計在2024年第四季度進行銷售,並在其貸款到期之前完成。如果銷售時間超過預期,我們有可選擇的方案來延長貸款到期,以便適應更長的銷售期間。 截至2022年12月31日,我們最大租戶哈里伯頓的租約到期。哈里伯頓位於我們在科羅拉多州的Shea Center II物業,約占我們年基地租金的536,080美元。哈里伯頓並未續簽租約,我們與貸款方一起將約110萬放入準備賬戶,以備未來的抵押貸款支付需要,截至2023年12月31日,這筆資金均未被使用。我們的管理團隊正在努力填補45,535平方英尺的空間,在2023年和2024年期間,我們已將約35%的空間租給了一位租戶,並已對剩餘65%的空間進行了各種提案的審查。截至2024年9月30日,管理層正在尋找符合我們長期計劃的第三方租戶,然而,我們並不能保證能成功簽約新租戶。 截至2024年6月30日,有五座樣板房被列為已持有待售的房地產資產。作為截至2024年6月30日,我們的樣板房的抵押貸款票據利率在每年4.51%到8.0%之間。 大太平洋中心,北達科他州比斯馬克於2022年12月7日簽署與KLJ工程的一項主要租約後,從待售資產中移除,租約約為33,296平方英尺,可用的租期為122個月,開始的年化租金為532,736美元。KLJ工程於2023年12月搬入該建築,租金自2024年2月28日開始。 00010806572024-01-012024-09-30 0001080657美元指數:普通A類成員2024-01-012024-09-30 0001080657平方英尺:系列D累積可贖回永久優先股成員2024-01-012024-09-30 0001080657平方英尺:系列A普通股認購權證成員2024-01-012024-09-30 xbrli:股份 00010806572024-11-18 thunderdome:項目 iso4217:美元指數 00010806572024-09-30 00010806572023-12-31 iso4217:美元指數xbrli:股份 0001080657us-gaap:系列D優先股成員2024-09-30 0001080657us-gaap:系列D優先股成員2023-12-31 0001080657美元指數:普通A類成員2024-09-30 0001080657美元指數:普通A類成員2023-12-31 00010806572024-07-012024-09-30 00010806572023-07-012023-09-30 00010806572023-01-012023-09-30 0001080657平方英尺 : 抵押貸款票據成員2024-07-012024-09-30 0001080657平方英尺 : 抵押貸款票據成員2023-07-012023-09-30 0001080657平方英尺 : 抵押貸款票據成員2024-01-012024-09-30 0001080657平方英尺 : 抵押貸款票據成員2023-01-012023-09-30 0001080657美元指數:優先股份成員2023-12-31 0001080657美元指數:普通股份成員2023-12-31 0001080657美元指數:額外實收資本成員2023-12-31 0001080657美元指數:保留盈餘成員2023-12-31 0001080657美元指數:母公司會員2023-12-31 0001080657us-gaap: 非控制權益會員2023-12-31 0001080657美元指數:優先股份成員2024-01-012024-03-31 0001080657美元指數:普通股份成員2024-01-012024-03-31 0001080657美元指數:額外實收資本成員2024-01-012024-03-31 0001080657美元指數:保留盈餘成員2024-01-012024-03-31 0001080657美元指數:母公司會員2024-01-012024-03-31 0001080657us-gaap: 非控制權益會員2024-01-012024-03-31 00010806572024-01-012024-03-31 0001080657us-gaap:系列D優先股成員美元指數:優先股份成員2024-01-012024-03-31 0001080657us-gaap:系列D優先股成員美元指數:普通股份成員2024-01-012024-03-31 0001080657us-gaap:系列D優先股成員美元指數:額外實收資本成員2024-01-012024-03-31 0001080657us-gaap:系列D優先股成員美元指數:保留盈餘成員2024-01-012024-03-31 0001080657us-gaap:系列D優先股成員美元指數:母公司會員2024-01-012024-03-31 0001080657us-gaap:系列D優先股成員us-gaap: 非控制權益會員2024-01-012024-03-31 0001080657us-gaap:系列D優先股成員2024-01-012024-03-31 0001080657美元指數:優先股份成員2024-03-31 0001080657美元指數:普通股份成員2024-03-31 0001080657美元指數:額外實收資本成員2024-03-31 0001080657美元指數:保留盈餘成員2024-03-31 0001080657美元指數:母公司會員2024-03-31 0001080657us-gaap: 非控制權益會員2024-03-31 00010806572024-03-31 0001080657美元指數:優先股份成員2024-04-012024-06-30 0001080657美元指數:普通股份成員2024-04-012024-06-30 0001080657美元指數:額外實收資本成員2024-04-012024-06-30 0001080657美元指數:保留盈餘成員2024-04-012024-06-30 0001080657美元指數:母公司會員2024-04-012024-06-30 0001080657us-gaap: 非控制權益會員2024-04-012024-06-30 00010806572024-04-012024-06-30 0001080657us-gaap:系列D優先股成員美元指數:優先股份成員2024-04-012024-06-30 0001080657us-gaap:系列D優先股成員美元指數:普通股份成員2024-04-012024-06-30 0001080657us-gaap:系列D優先股成員美元指數:額外實收資本成員2024-04-012024-06-30 0001080657us-gaap:系列D優先股成員美元指數:保留盈餘成員2024-04-012024-06-30 0001080657us-gaap:系列D優先股成員美元指數:母公司會員2024-04-012024-06-30 0001080657us-gaap:系列D優先股成員us-gaap: 非控制權益會員2024-04-012024-06-30 0001080657us-gaap:系列D優先股成員2024-04-012024-06-30 0001080657美元指數:普通A類成員美元指數:優先股份成員2024-04-012024-06-30 0001080657美元指數:普通A類成員美元指數:普通股份成員2024-04-012024-06-30 0001080657美元指數:普通A類成員美元指數:額外實收資本成員2024-04-012024-06-30 0001080657美元指數:普通A類成員美元指數:保留盈餘成員2024-04-012024-06-30 0001080657美元指數:普通A類成員美元指數:母公司會員2024-04-012024-06-30 0001080657美元指數:普通A類成員us-gaap: 非控制權益會員2024-04-012024-06-30 0001080657美元指數:普通A類成員2024-04-012024-06-30 0001080657美元指數:優先股份成員2024-06-30 0001080657美元指數:普通股份成員2024-06-30 0001080657美元指數:額外實收資本成員2024-06-30 0001080657美元指數:保留盈餘成員2024-06-30 0001080657美元指數:母公司會員2024-06-30 0001080657us-gaap: 非控制權益會員2024-06-30 00010806572024-06-30 0001080657美元指數:優先股份成員2024-07-012024-09-30 0001080657美元指數:普通股份成員2024-07-012024-09-30 0001080657美元指數:額外實收資本成員2024-07-012024-09-30 0001080657美元指數:保留盈餘成員2024-07-012024-09-30 0001080657美元指數:母公司會員2024-07-012024-09-30 0001080657us-gaap: 非控制權益會員2024-07-012024-09-30 0001080657us-gaap:系列D優先股成員美元指數:優先股份成員2024-07-012024-09-30 0001080657us-gaap:系列D優先股成員美元指數:普通股份成員2024-07-012024-09-30 0001080657us-gaap:系列D優先股成員美元指數:額外實收資本成員2024-07-012024-09-30 0001080657us-gaap:系列D優先股成員美元指數:保留盈餘成員2024-07-012024-09-30 0001080657us-gaap:系列D優先股成員美元指數:母公司會員2024-07-012024-09-30 0001080657us-gaap:系列D優先股成員us-gaap: 非控制權益會員2024-07-012024-09-30 0001080657us-gaap:系列D優先股成員2024-07-012024-09-30 0001080657美元指數:普通A類成員美元指數:優先股份成員2024-07-012024-09-30 0001080657美元指數:普通A類成員美元指數:普通股份成員2024-07-012024-09-30 0001080657美元指數:普通A類成員美元指數:額外實收資本成員2024-07-012024-09-30 0001080657美元指數:普通A類成員美元指數:保留盈餘成員2024-07-012024-09-30 0001080657美元指數:普通A類成員美元指數:母公司會員2024-07-012024-09-30 0001080657美元指數:普通A類成員us-gaap: 非控制權益會員2024-07-012024-09-30 0001080657美元指數:普通A類成員2024-07-012024-09-30 0001080657美元指數:優先股份成員2024-09-30 0001080657美元指數:普通股份成員2024-09-30 0001080657美元指數:額外實收資本成員2024-09-30 0001080657美元指數:保留盈餘成員2024-09-30 0001080657美元指數:母公司會員2024-09-30 0001080657us-gaap: 非控制權益會員2024-09-30 0001080657美元指數:優先股份成員2022-12-31 0001080657美元指數:普通股份成員2022-12-31 0001080657美元指數:額外實收資本成員2022-12-31 0001080657美元指數:保留盈餘成員2022-12-31 0001080657美元指數:母公司會員2022-12-31 0001080657us-gaap: 非控制權益會員2022-12-31 00010806572022-12-31 0001080657美元指數:優先股份成員2023-01-012023-03-31 0001080657美元指數:普通股份成員2023-01-012023-03-31 0001080657美元指數:額外實收資本成員2023-01-012023-03-31 0001080657美元指數:保留盈餘成員2023-01-012023-03-31 0001080657美元指數:母公司會員2023-01-012023-03-31 0001080657us-gaap: 非控制權益會員2023-01-012023-03-31 00010806572023-01-012023-03-31 0001080657美元指數:普通A類成員美元指數:優先股份成員2023-01-012023-03-31 0001080657美元指數:普通A類成員美元指數:普通股份成員2023-01-012023-03-31 0001080657美元指數:普通A類成員美元指數:額外實收資本成員2023-01-012023-03-31 0001080657美元指數:普通A類成員美元指數:保留盈餘成員2023-01-012023-03-31 0001080657美元指數:普通A類成員美元指數:母公司會員2023-01-012023-03-31 0001080657美元指數:普通A類成員us-gaap: 非控制權益會員2023-01-012023-03-31 0001080657美元指數:普通A類成員2023-01-012023-03-31 0001080657us-gaap:系列D優先股成員美元指數:優先股份成員2023-01-012023-03-31 0001080657us-gaap:系列D優先股成員美元指數:普通股份成員2023-01-012023-03-31 0001080657us-gaap:系列D優先股成員美元指數:額外實收資本成員2023-01-012023-03-31 0001080657us-gaap:系列D優先股成員美元指數:保留盈餘成員2023-01-012023-03-31 0001080657us-gaap:系列D優先股成員美元指數:母公司會員2023-01-012023-03-31 0001080657us-gaap:系列D優先股成員us-gaap: 非控制權益會員2023-01-012023-03-31 0001080657us-gaap:系列D優先股成員2023-01-012023-03-31 0001080657美元指數:優先股份成員2023-03-31 0001080657美元指數:普通股份成員2023-03-31 0001080657美元指數:額外實收資本成員2023-03-31 0001080657美元指數:保留盈餘成員2023-03-31 0001080657美元指數:母公司會員2023-03-31 0001080657us-gaap: 非控制權益會員2023-03-31 00010806572023-03-31 0001080657美元指數:優先股份成員2023-04-012023-06-30 0001080657美元指數:普通股份成員2023-04-012023-06-30 0001080657美元指數:額外實收資本成員2023-04-012023-06-30 0001080657美元指數:保留盈餘成員2023-04-012023-06-30 0001080657美元指數:母公司會員2023-04-012023-06-30 0001080657us-gaap: 非控制權益會員2023-04-012023-06-30 00010806572023-04-012023-06-30 0001080657美元指數:普通A類成員美元指數:優先股份成員2023-04-012023-06-30 0001080657美元指數:普通A類成員美元指數:普通股份成員2023-04-012023-06-30 0001080657美元指數:普通A類成員美元指數:額外實收資本成員2023-04-012023-06-30 0001080657美元指數:普通A類成員美元指數:保留盈餘成員2023-04-012023-06-30 0001080657美元指數:普通A類成員美元指數:母公司會員2023-04-012023-06-30 0001080657美元指數:普通A類成員us-gaap: 非控制權益會員2023-04-012023-06-30 0001080657美元指數:普通A類成員2023-04-012023-06-30 0001080657us-gaap:系列D優先股成員美元指數:優先股份成員2023-04-012023-06-30 0001080657us-gaap:系列D優先股成員美元指數:普通股份成員2023-04-012023-06-30 0001080657us-gaap:系列D優先股成員美元指數:額外實收資本成員2023-04-012023-06-30 0001080657us-gaap:系列D優先股成員美元指數:保留盈餘成員2023-04-012023-06-30 0001080657us-gaap:系列D優先股成員美元指數:母公司會員2023-04-012023-06-30 0001080657us-gaap:系列D優先股成員us-gaap: 非控制權益會員2023-04-012023-06-30 0001080657us-gaap:系列D優先股成員2023-04-012023-06-30 0001080657美元指數:優先股份成員2023-06-30 0001080657美元指數:普通股份成員2023-06-30 0001080657美元指數:額外實收資本成員2023-06-30 0001080657美元指數:保留盈餘成員2023-06-30 0001080657美元指數:母公司會員2023-06-30 0001080657us-gaap: 非控制權益會員2023-06-30 00010806572023-06-30 0001080657美元指數:優先股份成員2023-07-012023-09-30 0001080657美元指數:普通股份成員2023-07-012023-09-30 0001080657美元指數:額外實收資本成員2023-07-012023-09-30 0001080657美元指數:保留盈餘成員2023-07-012023-09-30 0001080657美元指數:母公司會員2023-07-012023-09-30 0001080657us-gaap: 非控制權益會員2023-07-012023-09-30 0001080657美元指數:普通A類成員美元指數:優先股份成員2023-07-012023-09-30 0001080657美元指數:普通A類成員美元指數:普通股份成員2023-07-012023-09-30 0001080657美元指數:普通A類成員美元指數:額外實收資本成員2023-07-012023-09-30 0001080657美元指數:普通A類成員美元指數:保留盈餘成員2023-07-012023-09-30 0001080657美元指數:普通A類成員美元指數:母公司會員2023-07-012023-09-30 0001080657美元指數:普通A類成員us-gaap: 非控制權益會員2023-07-012023-09-30 0001080657美元指數:普通A類成員2023-07-012023-09-30 0001080657us-gaap:系列D優先股成員美元指數:優先股份成員2023-07-012023-09-30 0001080657us-gaap:系列D優先股成員美元指數:普通股份成員2023-07-012023-09-30 0001080657us-gaap:系列D優先股成員美元指數:額外實收資本成員2023-07-012023-09-30 0001080657us-gaap:系列D優先股成員美元指數:保留盈餘成員2023-07-012023-09-30 0001080657us-gaap:系列D優先股成員美元指數:母公司會員2023-07-012023-09-30 0001080657us-gaap:系列D優先股成員us-gaap: 非控制權益會員2023-07-012023-09-30 0001080657us-gaap:系列D優先股成員2023-07-012023-09-30 0001080657美元指數:優先股份成員2023-09-30 0001080657美元指數:普通股份成員2023-09-30 0001080657美元指數:額外實收資本成員2023-09-30 0001080657美元指數:保留盈餘成員2023-09-30 0001080657美元指數:母公司會員2023-09-30 0001080657us-gaap: 非控制權益會員2023-09-30 00010806572023-09-30 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員2024-01-012024-09-30 0001080657平方英尺 : Conduit Pharmaceuticals Inc 會員2023-01-012023-09-30 0001080657平方英尺 : 除了Conduit會員之外的所有其他2024-01-012024-09-30 0001080657平方英尺 : 除了Conduit會員之外的所有其他2023-01-012023-09-30 0001080657us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657美元指數:普通A類成員2023-09-30 0001080657us-gaap:系列D優先股成員2023-09-30 純種成員 0001080657平方英尺 : 商業房地產成員2024-09-30 0001080657平方英尺 : 商業房地產成員us-gaap: 部分擁有物業成員2024-09-30 0001080657平方英尺 : 樣板房地產成員2024-01-012024-09-30 0001080657平方英尺 : 抵押貸款票據成員2024-09-30 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 樣板房地產成員2024-09-30 0001080657平方英尺 : 特殊目的收購公司 SPAC 成員2023-09-21 0001080657平方英尺 : 將B類轉換為A類普通股成員平方英尺 : Conduit Pharmaceuticals Inc 成員2023-09-222023-09-22 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員2023-09-222023-09-22 0001080657平方英尺 : 私人認股權證成員平方英尺 : Conduit Pharmaceuticals Inc 成員2023-09-22 0001080657平方英尺 : 私人認股權證成員平方英尺 : Murphy Canyon Acquisition Sponsor LLCSPAC 成員美元指數:普通A類成員2023-09-22 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員服務: Director 會員2023-09-222023-09-30 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員服務: Director 會員2023-09-30 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員2023-09-30 0001080657平方英尺 : Murphy Canyon Acquisition Sponsor LLCSPAC 成員2023-09-22 utr:Y 0001080657美元指數:租地改良成員srt:最大會員2024-09-30 0001080657平方英尺 : 有限壽命無形資產,除了租賃無形資產的成員2024-07-012024-09-30 0001080657平方英尺 : 有限壽命無形資產,除了租賃無形資產的成員2024-01-012024-09-30 0001080657平方英尺 : 有限壽命無形資產,除了租賃無形資產的成員2023-07-012023-09-30 0001080657平方英尺 : 有限壽命無形資產,除了租賃無形資產的成員2023-01-012023-09-30 0001080657us-gaap:家具和裝置成員srt:最小成員2024-09-30 0001080657us-gaap:家具和裝置成員srt:最大會員2024-09-30 0001080657srt:最小成員2024-09-30 0001080657平方英尺 : 標準房屋會員2024-01-012024-09-30 0001080657平方英尺 : 標準房屋會員2024-07-012024-09-30 0001080657平方英尺 : 達科他中心會員2024-07-012024-09-30 0001080657平方英尺 : 達科他中心會員2024-01-012024-09-30 0001080657平方英尺 : 標準房屋物業會員2024-07-012024-09-30 0001080657平方英尺 : 標準房屋物業會員2024-01-012024-09-30 0001080657us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2024-09-30 0001080657美元指數:公平價值輸入一級會員2023-12-31 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員2024-04-22 0001080657平方英尺 : 私人期權成員平方英尺 : Conduit Pharmaceuticals Inc 成員2024-04-22 0001080657平方英尺 : 私人期權成員平方英尺 : Conduit Pharmaceuticals Inc 成員2024-04-222024-04-22 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員2024-09-30 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員2023-12-31 0001080657平方英尺 : 普通股期權成員2024-07-012024-09-30 0001080657平方英尺 : 普通股期權成員2023-07-012023-09-30 0001080657平方英尺 : 普通股期權成員2024-01-012024-09-30 0001080657平方英尺 : 普通股期權成員2023-01-012023-09-30 0001080657平方英尺 : 配置代理期權成員2024-07-012024-09-30 0001080657平方英尺 : 配置代理期權成員2023-07-012023-09-30 0001080657平方英尺 : 配置代理期權成員2024-01-012024-09-30 0001080657平方英尺 : 配置代理期權成員2023-01-012023-09-30 0001080657平方英尺 : A系列期權成員2024-07-012024-09-30 0001080657平方英尺 : A系列期權成員2023-07-012023-09-30 0001080657平方英尺 : A系列期權成員2024-01-012024-09-30 0001080657平方英尺 : A系列期權成員2023-01-012023-09-30 0001080657平方英尺 : 未歸屬普通股授予成員2024-07-012024-09-30 0001080657平方英尺 : 未歸屬普通股授予成員2023-07-012023-09-30 0001080657平方英尺 : 未歸屬普通股授予成員2024-01-012024-09-30 0001080657平方尺 : 未歸屬的普通股授予成員2023-01-012023-09-30 0001080657SRT:修正先前期間錯誤更正調整成員2023-12-31 0001080657SRT:修正先前期間錯誤更正調整成員2023-01-012023-03-31 0001080657SRT:修正先前期間錯誤更正調整成員2023-04-012023-06-30 0001080657SRT:修正先前期間錯誤更正調整成員2023-07-012023-09-30 0001080657SRT:修正先前期間錯誤更正調整成員2024-01-012024-03-31 0001080657平方尺 : 建築及租戶改善成員2023-09-30 0001080657平方尺 : 建築及租戶改善成員2023-12-31 0001080657報告原本通報成員的情境2023-01-012023-09-30 0001080657srt:重編調整成員2023-01-012023-09-30 0001080657srt:重編調整成員2024-01-012024-03-31 0001080657srt:重編調整成員2024-01-012024-06-30 0001080657平方英尺 : 標準住宅會員2024-09-30 0001080657平方英尺 : 按揭備忘錄會員平方英尺 : 標準住宅會員2024-09-30 0001080657平方英尺 : 標準住宅會員2023-09-30 0001080657平方英尺 : 樣板房會員2023-01-012023-09-30 0001080657平方英尺 : 抵押貸款票據會員平方英尺 : 樣板房會員2023-09-30 0001080657us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2024-01-012024-09-30 0001080657us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2023-09-30 0001080657us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2023-01-012023-09-30 0001080657國家:CO2024-09-30 0001080657年利率:ND2024-09-30 0001080657stpr: CA2024-09-30 0001080657stpr:TX2024-09-30 0001080657stpr:MD2024-09-30 0001080657平方英尺:辦公大樓成員平方英尺:辦公工業物業成員2024-09-30 0001080657srt : Office Building Member平方英尺:辦公工業物業成員2024-09-30 英亩 0001080657平方英尺 : 辦公室工業性質成員2024-09-30 0001080657srt:零售網站會員平方英尺 : 零售性質成員2024-09-30 平方英尺 0001080657平方英尺 : 零售性質成員2024-09-30 0001080657平方英尺 : 模型住宅性質成員2024-09-30 0001080657平方英尺 : 模型住宅成員2024-01-012024-09-30 0001080657平方英尺 : 創世廣場成員2024-01-012024-09-30 0001080657平方英尺 : 基因廣場會員2024-09-30 0001080657平方英尺 : 基因廣場會員2023-12-31 0001080657平方英尺 : 道科大中心會員2024-09-30 0001080657平方英尺 : 道科大中心會員2023-12-31 0001080657平方英尺 : 大太平洋中心會員2024-01-012024-09-30 0001080657平方英尺 : 大太平洋中心會員2024-09-30 0001080657平方英尺 : 大太平洋中心會員2023-12-31 0001080657平方英尺 : 阿拉帕霍中心會員2024-01-012024-09-30 0001080657平方尺 : 阿拉帕霍中心會員2024-09-30 0001080657平方尺 : 阿拉帕霍中心會員2023-12-31 0001080657平方尺 : 聯合城鎮中心會員2024-01-012024-09-30 0001080657平方尺 : 聯合城鎮中心會員2024-09-30 0001080657平方尺 : 聯合城鎮中心會員2023-12-31 0001080657平方尺 : 西法argo工業會員2024-01-012024-09-30 0001080657平方尺 : 西法argo工業會員2024-09-30 0001080657平方尺 : 西法argo工業會員2023-12-31 0001080657平方英尺 : 第300 NP成員2024-01-012024-09-30 0001080657平方英尺 : 第300 NP成員2024-09-30 0001080657平方英尺 : 第300 NP成員2023-12-31 0001080657平方英尺 : 研究公園成員2024-01-012024-09-30 0001080657平方英尺 : 研究公園成員2024-09-30 0001080657平方英尺 : 研究公園成員2023-12-31 0001080657平方英尺 : 一公園中心成員2024-01-012024-09-30 0001080657平方英尺 : 一公園中心成員2024-09-30 0001080657平方英尺 : One Park Centre 會員2023-12-31 0001080657平方英尺 : Shea Center II 會員2024-01-012024-09-30 0001080657平方英尺 : Shea Center II 會員2024-09-30 0001080657平方英尺 : Shea Center II 會員2023-12-31 0001080657平方英尺 : Mandolin 會員2024-01-012024-09-30 0001080657平方英尺 : Mandolin 會員2024-09-30 0001080657平方英尺 : Mandolin 會員2023-12-31 0001080657平方英尺 : Baltimore 會員2024-01-012024-09-30 0001080657平方英尺 : 巴爾的摩成員2024-09-30 0001080657平方英尺 : 巴爾的摩成員2023-12-31 0001080657平方英尺 : presidio property trust Inc 資產成員2024-09-30 0001080657平方英尺 : presidio property trust Inc 資產成員2023-12-31 0001080657平方英尺 : 樣板房資產成員2024-09-30 0001080657平方英尺 : 樣板房資產成員2023-12-31 0001080657平方英尺 : 共同租戶一成員平方英尺 : 創世廣場成員2024-09-30 0001080657平方英尺 : 共同租戶兩名成員平方英尺 : 創世廣場成員2024-09-30 0001080657平方英尺 : Netreit創世成員2024-09-30 0001080657平方英尺 : Netreit創世二成員2024-09-30 0001080657平方英尺 : Netreit創世二成員美元指數:普通A類成員平方英尺 : 股份發行以進行所有權交易成員2024-07-012024-07-31 0001080657平方英尺 : Netreit創世二成員美元指數:普通A類成員平方英尺 : 發行股份用於所有權交易所成員2024-07-012024-07-31 0001080657平方英尺 : 大太平洋中心成員2022-12-07 0001080657平方英尺 : 大太平洋中心成員2022-12-072022-12-07 0001080657平方英尺 : 一公園中心成員2023-01-012023-12-31 0001080657平方英尺 : 谢亚中心 II 成員2022-12-312022-12-31 0001080657平方英尺 : 谢亚中心 II 成員2022-12-31 0001080657平方英尺 : 淨REIT Palm自存倉 LP 成員2024-09-30 0001080657美元指數:購置租賃成員2024-09-30 0001080657美元指數:購置租賃成員2023-12-31 0001080657平方英尺 : 租賃成本成員2024-09-30 0001080657平方英尺 : 租賃成本成員2023-12-31 0001080657平方英尺 : 高於市場租約成員2024-09-30 0001080657平方英尺 : 高於市場租約成員2023-12-31 0001080657平方英尺 : 待售房地產資產成員2024-09-30 0001080657平方英尺 : 待售房地產資產成員2023-12-31 0001080657平方英尺 : 傳票型期權合約成員平方英尺 : 可售證券房地產投資信託成員2023-12-31 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 達科他中心成員2024-09-30 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 達科他中心成員2023-12-31 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 研究公園成員2024-09-30 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 研究公園成員2023-12-31 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 阿拉帕荷中心成員2024-09-30 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 阿拉帕荷中心成員2023-12-31 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 聯合城中心成員2024-09-30 0001080657平方英尺 : 抵押貸款票據會員平方英尺 : 聯合市中心會員2023-12-31 0001080657平方英尺 : 抵押貸款票據會員平方英尺 : 一公園中心會員2024-09-30 0001080657平方英尺 : 抵押貸款票據會員平方英尺 : 一公園中心會員2023-12-31 0001080657平方英尺 : 抵押貸款票據會員平方英尺 : 創世廣場會員2024-09-30 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 創世廣場成員2023-12-31 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 蛇中心II成員2024-09-30 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 蛇中心II成員2023-12-31 0001080657平方英尺 : 抵押貸款票據成員平方英尺 : 西法戈工業成員2024-09-30 0001080657平方英尺 : 按揭票據成員平方英尺 : 西法哥工業成員2023-12-31 0001080657平方英尺 : 按揭票據成員平方英尺 : 大洋洲中心成員2024-09-30 0001080657平方英尺 : 按揭票據成員平方英尺 : 大洋洲中心成員2023-12-31 0001080657平方英尺 : 按揭票據成員平方英尺 : 巴爾的摩成員2024-09-30 0001080657平方英尺 : 抵押貸款證券會員平方英尺 : 巴爾的摩會員2023-12-31 0001080657平方英尺 : 抵押貸款證券會員平方英尺 : 曼多林會員2024-09-30 0001080657平方英尺 : 抵押貸款證券會員平方英尺 : 曼多林會員2023-12-31 0001080657平方英尺 : 抵押貸款證券會員平方英尺 : 小計 presidio property trust Inc 資產會員2024-09-30 0001080657平方英尺 : 持有按揭票據成員平方英尺 : 總計presidio property trust資產成員2023-12-31 0001080657平方英尺 : 持有按揭票據成員平方英尺 : 標準樣板房成員2023-12-31 0001080657平方英尺 : 持有按揭票據成員2023-12-31 0001080657平方英尺 : 持有西法戈工業房地產的按揭貸款成員2024-06-20 0001080657平方英尺 : 持有西法戈工業房地產的按揭貸款成員2024-06-202024-06-20 0001080657平方英尺 : 大太平洋中心成員2023-05-05 0001080657平方英尺 : 再融資貸款成員2023-05-05 0001080657平方英尺 : 再融資貸款成員2023-05-052023-05-05 0001080657平方英尺 : 施工貸款成員2023-05-05 0001080657平方英尺 : 施工貸款成員2023-05-052023-05-05 0001080657平方英尺 : 施工貸款成員2024-09-30 0001080657平方英尺 : 抵押貸款票據成員srt:最小成員平方英尺 : 樣板房成員2024-09-30 0001080657平方英尺 : 抵押貸款票據會員srt:最大會員平方英尺 : 樣板房會員2024-09-30 0001080657平方英尺 : 抵押貸款票據會員平方英尺 : 樣板房會員2024-09-30 0001080657平方英尺 : presidio property trust Inc 貸款票據會員2024-09-30 0001080657平方英尺 : 樣板房資產貸款票據會員2024-09-30 0001080657平方英尺 : 經濟損傷災難貸款會員2020-04-222020-04-22 0001080657平方英尺:經濟傷害災難貸款成員2020-08-172020-08-17 0001080657平方英尺:經濟傷害災難貸款成員2024-09-30 0001080657平方英尺:再融資一棟模型住宅的本票成員平方英尺:多數擁有的子公司Dubose模型住宅投資者202 LP和204 LP成員2024-09-30 0001080657平方英尺:再融資一棟模型住宅的本票成員平方英尺:多數擁有的子公司Dubose模型住宅投資者202 LP和204 LP成員2024-08-15 0001080657平方英尺:Murphy Canyon收購發起公司成員平方英尺:SPAC首次公開募股成員2022-01-072022-01-07 0001080657平方英尺 : 墨菲峽收購贊助商有限責任公司成員平方英尺 : 特殊目的收購公司首次公開募股成員2022-01-07 0001080657平方英尺 : 墨菲峽收購贊助商有限責任公司成員平方英尺 : 特殊目的收購公司首次公開募股成員2022-02-072022-02-07 0001080657平方英尺 : 墨菲峽收購贊助商有限責任公司成員平方英尺 : 特殊目的收購公司首次公開募股成員2022-02-07 0001080657平方英尺 : 合併對價成員2023-01-262023-01-26 0001080657平方英尺 : 信託為特殊目的收購公司A類普通股股東成員2023-01-012023-06-30 0001080657平方英尺 : SPAC A類普通股股東信託成員2023-02-012023-02-28 0001080657平方英尺 : SPAC A類普通股股東信託成員2023-06-30 0001080657美元指數:普通A類成員2023-03-01 0001080657平方英尺 : 墨菲峽谷收購贊助商有限責任公司成員2023-05-11 0001080657平方英尺 : SPAC A類普通股股東信託成員2023-01-012023-09-30 0001080657平方英尺 : 特殊目的收購公司SPAC成員2023-09-22 0001080657平方英尺 : 私人認股權證成員平方英尺 : 管道製藥公司成員美元指數:普通A類成員2023-09-22 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員服務: Director 會員2023-09-222023-09-22 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員服務: Director 會員2023-09-22 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員2023-09-22 0001080657平方英尺 : Conduit Pharmaceuticals Inc 成員2024-09-30 0001080657平方英尺 : Murphy Canyon Acquisition Sponsor LLC 成員2023-09-222023-12-31 0001080657平方英尺 : 墨菲峽谷收購贊助商有限責任公司成員2023-09-222023-09-22 0001080657美元指數:普通股份成員平方英尺 : 管道製藥公司成員2024-09-30 0001080657美元指數:認股權證成員平方英尺 : 管道製藥公司成員2024-09-30 0001080657平方英尺 : 私人權證成員平方英尺 : 管道製藥公司成員2024-09-30 00010806572024-04-012024-09-30 0001080657us-gaap:系列D優先股成員2021-06-152021-06-15 0001080657us-gaap:系列D優先股成員2021-06-15 utr:D 0001080657us-gaap:系列D優先股成員us-gaap:超額配售選項成員2021-06-152021-06-15 0001080657us-gaap:系列D優先股成員us-gaap:超額配售選項成員2021-06-172021-06-17 0001080657us-gaap:系列D優先股成員2021-06-152021-06-17 0001080657平方英尺 : 基準公司會員平方英尺 : 擔保公開發行成員2024-06-202024-06-24 0001080657平方英尺 : 基準公司成員平方英尺 : 擔保公開發行成員2024-06-24 0001080657平方英尺 : O 2024 H 2 股息成員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657美元指數:普通B類股份2024-09-30 0001080657us-gaap:普通類別C成員2024-09-30 0001080657平方英尺 : 首席執行官及首席投資官成員2024-09-30 0001080657美元指數:普通A類成員2021-07-122021-07-12 0001080657平方英尺 : 普通股認股權證成員2021-07-12 0001080657平方英尺 : 預資認股權證成員2021-07-12 0001080657平方英尺 : A類普通股及其配套普通股認股權證成員2021-07-12 0001080657平方英尺 : A類普通股及其配套預資認股權證成員2021-07-12 0001080657平方英尺 : 配置代理認股權證成員2021-08-31 0001080657平方英尺 : 普通股認股權證及配置代理認股權證成員2024-01-012024-06-30 0001080657平方英尺 : Netreit Genesis II成員美元指數:普通A類成員平方英尺 : 針對所有板塊交易所的股份發行2024-07-31 0001080657美元指數:普通A類成員2022-09-15 0001080657us-gaap:系列D優先股成員2022-09-15 0001080657美元指數:普通A類成員2023-12-01 0001080657us-gaap:系列D優先股成員2023-12-01 0001080657us-gaap:系列D優先股成員2023-01-012023-12-31 0001080657平方英尺 : A系列普通股成員2024-01-012024-09-30 0001080657平方英尺 : A系列普通股成員2024-07-012024-09-30 0001080657平方英尺 : A系列普通股成員2023-07-012023-09-30 0001080657平方英尺 : A系列普通股成員2023-01-012023-09-30 0001080657平方英尺 : O 2024年第一季股息成員美元指數:普通A類成員2024-01-012024-09-30 0001080657平方英尺 : O 2023年第一季股息成員美元指數:普通A類成員2023-01-012023-09-30 0001080657平方英尺 : O 2024年第二季股息成員美元指數:普通A類成員2024-01-012024-09-30 0001080657平方英尺 : O 2023年第2季度股息會員美元指數:普通A類成員2023-01-012023-09-30 0001080657平方英尺 : O 2024年第3季度股息會員美元指數:普通A類成員2024-01-012024-09-30 0001080657平方英尺 : O 2023年第3季度股息會員美元指數:普通A類成員2023-01-012023-09-30 0001080657美元指數:普通A類成員2023-01-012023-09-30 0001080657平方英尺 : O 2024 M 1 股息成員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657平方英尺 : O 2023 M 1 股息成員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657平方英尺 : O 2024 M 2 股息成員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657平方英尺 : O 2023 M 2 股息成員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657平方英尺:O 2024 M 3 股息會員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657平方英尺:O 2023 M 3 股息會員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657平方英尺:O 2024 M 4 股息會員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657平方英尺:O 2023 M 4 股息會員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657每平方英尺 : O 2024 M 5 股息會員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657每平方英尺 : O 2023 M 5 股息會員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657每平方英尺 : O 2024 M 6 股息會員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657每平方英尺 : O 2023 M 6 股息會員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657平方英尺 : O 2024 年 7 月 股息 成員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657平方英尺 : O 2023 年 7 月 股息 成員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657平方英尺 : O 2024 年 8 月 股息 成員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657平方英尺 : O 2023 年 8 月 股息 成員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657平方英尺 : O 2024 M 9 分紅 會員us-gaap:系列D優先股成員2024-01-012024-09-30 0001080657平方英尺 : O 2023 M 9 分紅 會員us-gaap:系列D優先股成員2023-01-012023-09-30 0001080657us-gaap:限制性股票成員srt:最小成員2024-01-012024-09-30 0001080657us-gaap:限制性股票成員srt:最大會員2024-01-012024-09-30 0001080657us-gaap:限制性股票成員2006-12-31 0001080657平方英尺 : 2017年激勵獎勵計劃成員2017-12-31 0001080657平方英尺 : 2017年激勵獎勵計劃成員2022-05-26 0001080657平方英尺 : 2017年激勵獎勵計劃成員2023-06-01 0001080657us-gaap:限制性股票成員2023-12-31 0001080657us-gaap:限制性股票成員2024-01-012024-09-30 0001080657us-gaap:限制性股票成員2024-09-30 0001080657平方英尺 : 非完全歸屬限制股票成員srt:最小成員2024-01-012024-09-30 0001080657平方英尺 : 非持有限制股票成員srt:最大會員2024-01-012024-09-30 0001080657平方英尺 : 2017年獎勵計畫成員2024-09-30 0001080657us-gaap:限制性股票成員SRT:首席執行官成員2024-01-012024-09-30 0001080657us-gaap:營運區域成員平方英尺 : 辦公室工業不動產成員2024-07-012024-09-30 0001080657us-gaap:營運區域成員平方英尺 : 辦公室工業物業會員2023-07-012023-09-30 0001080657us-gaap:營運區域成員平方英尺 : 辦公室工業物業會員2024-01-012024-09-30 0001080657us-gaap:營運區域成員平方英尺 : 辦公室工業物業會員2023-01-012023-09-30 0001080657us-gaap:營運區域成員平方英尺 : 樣板房物業會員2024-07-012024-09-30 0001080657us-gaap:營運區域成員平方英尺 : 樣板房產會員2023-07-012023-09-30 0001080657us-gaap:營運區域成員平方英尺 : 樣板房產會員2024-01-012024-09-30 0001080657us-gaap:營運區域成員平方英尺 : 樣板房產會員2023-01-012023-09-30 0001080657us-gaap:營運區域成員平方英尺 : 零售房產會員2024-07-012024-09-30 0001080657us-gaap:營運區域成員平方呎 : 零售物業會員2023-07-012023-09-30 0001080657us-gaap:營運區域成員平方呎 : 零售物業會員2024-01-012024-09-30 0001080657us-gaap:營運區域成員平方呎 : 零售物業會員2023-01-012023-09-30 0001080657us-gaap:營運區域成員2024-07-012024-09-30 0001080657us-gaap:營運區域成員2023-07-012023-09-30 0001080657us-gaap:營運區域成員2024-01-012024-09-30 0001080657us-gaap:營運區域成員2023-01-012023-09-30 0001080657us-gaap:營運區域成員平方尺 : 辦公室工業物業成員2024-09-30 0001080657us-gaap:營運區域成員平方尺 : 辦公室工業物業成員2023-12-31 0001080657us-gaap:營運區域成員平方尺 : 標準住宅物業成員2024-09-30 0001080657us-gaap:營運區域成員平方尺 : 標準住宅物業成員2023-12-31 0001080657us-gaap:營運區域成員平方尺 : 零售物業成員2024-09-30 0001080657us-gaap:營運區域成員平方尺 : 零售物業成員2023-12-31 0001080657us-gaap:營運區域成員2024-09-30 0001080657us-gaap:營運區域成員2023-12-31 0001080657us-gaap:MaterialReconcilingItemsMember2024-09-30 0001080657us-gaap:MaterialReconcilingItemsMember2023-12-31 0001080657平方英尺 : 辦公室工業房地產會員2024-01-012024-09-30 0001080657平方英尺 : 辦公室工業房地產會員2023-01-012023-09-30 0001080657平方英尺 : 樣板房地產會員2023-01-012023-09-30 0001080657平方英尺 : 零售房地產會員2024-01-012024-09-30 0001080657平方英尺 : 零售房地產會員2023-01-012023-09-30 0001080657平方英尺 : REIT 子公司會員2024-01-012024-09-30 0001080657平方呎 : Trs Entities 成員2023-12-31 0001080657平方呎 : 公司總部的轉租成員srt:子公司成員2024-07-012024-09-30 0001080657平方呎 : 公司總部的轉租成員srt:子公司成員2024-01-012024-09-30 0001080657平方呎 : 公司總部的轉租成員srt:子公司成員2023-07-012023-09-30 0001080657平方呎 : 公司總部的轉租成員srt:子公司成員2023-01-012023-09-30 0001080657平方英尺 : 薪資補償成員srt:子公司成員2024-07-012024-09-30 0001080657平方英尺 : 薪資補償成員srt:子公司成員2024-01-012024-09-30 0001080657平方英尺 : 薪資補償成員srt:子公司成員2023-07-012023-09-30 0001080657平方英尺 : 薪資補償成員srt:子公司成員2023-01-012023-09-30 0001080657平方英尺 : 薪資報銷成員srt:子公司成員2024-09-30 0001080657平方英尺 : 薪資報銷成員srt:子公司成員2023-12-31 0001080657平方英尺 : 前首席財務官成員平方英尺 : Cdt普通股成員us-gaap:後續事件成員2024-10-012024-10-31 0001080657平方英尺:前首席財務官成員平方英尺:Cdt普通股成員us-gaap:後續事件成員2024-10-31 0001080657平方英尺:Cdt普通股成員平方英尺:Conduit Pharmaceuticals Inc成員us-gaap:後續事件成員2024-10-31 0001080657平方英尺:Cdttw權證成員平方英尺:Conduit Pharmaceuticals Inc成員us-gaap:後續事件成員2024-10-31 0001080657平方英尺 : 私人認股權證成員平方英尺 : 透管製藥公司成員us-gaap:後續事件成員2024-10-31
 
目錄

美國

證券和交易委員會

華盛頓特區 20549

___________________________________________________________

表格 10-Q

___________________________________________________________

 

根據1934年證券交易法第13或15(d)節的季度報告

截至季度結束日期的財務報告2024年9月30日

或者

根據1934年證券交易法第13或15(d)節的轉型報告書

從_____到_____期間

001-34049

(委託文件號)

___________________________________________________________

 

presidio property trust, INC.

(根據其章程規定的註冊人準確名稱)

___________________________________________________________

   

馬里蘭

 

33-0841255

(所在州或其他司法管轄區)
成立或組織文件

 

(國稅局僱主
識別號碼)

4995 Murphy Canyon Road,300號套房, 聖地亞哥, 加利福尼亞 92123

(主要行政辦公室地址)

 

(760) 471-8536

(註冊人的電話號碼,包括區號)

每一類已註冊證券的標題 交易標的: 在其上註冊的交易所的名稱
A系列普通股, 平方英尺 

納斯達克 股票市場 有限責任公司

每股面值$0.01    
     
9.375% D系列累積可贖回永久優先股, SQFTP 納斯達克 股票市場 有限責任公司
每股面值$0.01    
     
A輪普通股購買warrants SQFTW 納斯達克 股票市場 有限責任公司
購買普通股股票    
     

________________________________________________

 

請勾選此項,以指示註冊人是否在過去12個月(或者對於註冊人需要提交此類文件的期間更短)提交了每個互動數據文件的電子提交文件,該文件根據Regulation S-T的規則405(本章節的§232.405)(或者相當的市場季報表單規則)提交。 ☒ 否 ☐

請勾選表示公司自動在過去12個月內每個互動數據文件要求按照Regulation S-t的第405條規定提交(本章第232.405條)(或公司被要求提交此類文件的較短期間) ☒ 否 ☐

勾選表示註冊人是大型規模加速報告人、加速報告人、非加速報告人、小型報告公司或新興成長公司。請參閱證交所法規120億.2中「大型規模加速報告人」、「加速報告人」、「小型報告公司」和「新興成長公司」的定義。

大型加速報告人

 

加速文件提交人

非加速文件提交人

 

較小的報告公司

新興增長公司

   

如果是新興成長公司,請在複覈者處標明勾選符號,說明註冊者是否選擇不使用依據證券交易法第13(a)條規定提供的任何新的或修訂後的財務會計準則的擴展過渡期。 ☐

請用複選標記指示註冊 nt是一家s shell 公司(如 交易所法案第120億.2條所定義)。 是 否 ☒

2024年11月18日,註冊公司已發行並流通 14,404,308 股份 其A輪C系列每股普通股,面值爲$0.01。

 

 

 

 

 
索引

頁面

   

第一部分。基本報表信息:

5

項目 1. 基本報表:

5

2024年9月30日的合併資產負債表(未經審計)和2023年12月31日

5

2024年9月30日和2023年(未經審計)三個月和九個月的綜合收支表

6

2024年和2023年截至9月30日的三個月和九個月合併權益變動表(未經審計)

7

2024年9月30日和2023年(未經審計)九個月的現金流量表

9

合併財務報表註釋(未經審計)

10

第2項.管理層對財務狀況和經營業績的討論與分析

31

項目3.有關市場風險的數量和質量披露

41

項目4.控制和程序

41

第二部分. 其他信息

42

項目1.法律訴訟

42

Item 1A. Risk Factors

42

項目2. 未註冊的股權銷售和款項使用

42

項目3. 面對高級證券的違約情況

43

項目4. 礦業安全披露

43

項目5.其他信息

43

項目6.附件

44

簽名

45

 

 

2

 

 

有關前瞻性聲明的警告性用語

 

本報告包含依據《聯邦證券法》的"前瞻性陳述",涉及風險和不確定因素,其中許多超出我們的控制範圍。實際結果可能與此類前瞻性陳述中預期的結果存在重大和不利的差異,這是由於某些因素,包括本報告中列出的因素以及我們向美國證券交易委員會("SEC")提交的其他文件。前瞻性陳述涉及我們行業、業務策略、關於我們市場地位、未來運營、利潤率、盈利能力、資本支出、財務狀況、流動性、資本資源、現金流、經營業績和其他財務和運營信息的事項。 本報告中包含的前瞻性陳述包括但不限於有關購買和銷售物業、籌資及再融資我們的物業計劃、我們資本資源的充足性、我們所經營市場的變化、我們的業務計劃和策略以及我們的分紅支付。 在本報告中使用的"將"、"可能"、"相信"、"預計"、"計劃"、"估計"、"預期"、"應當"、"規劃"等類似表達,旨在識別前瞻性陳述,儘管並非所有前瞻性陳述都包含這些識別詞。可能導致實際結果與預期不符的重要因素包括但不限於:

 

 

與房地產業及房地產業投資相關的固有風險;

 

 

顯著的競爭可能會降低或阻止我們物業的入住率和租金上漲,並可能減少我們物業的價值;

 

 

商業空間需求下降和/或運營成本增加;

 

 

任何主要租戶(或大量租戶)因其財務狀況惡化、提前終止租約、不續租或以對我們不利的條款續租而未向我們支付租金的情況。

 

 

我們和我們的租戶面臨的經濟條件可能對我們的財務狀況和運營結果產生重大不利影響;

 

 

我們未能及時產生足夠的現金來償還或清償我們的債務責任。

 

 

我們無法借款或籌集足夠資金來維持和/或擴展我們的地產投資組合;

 

 

房地產融資市場的不利變化,包括利率期貨和/或借貸成本的潛在增加;

 

 

潛在損失,包括不利天氣條件、自然災害和產權索賠,可能不在保險範圍內;

 

 

無法完成收購或處置,即使完成這些交易,也可能無法成功運營收購的物業和/或賣出物業而不產生重大的贖回成本;

 

 

我們依賴第三方物業管理人員來管理大量物業,經紀人或代理人來出租我們的物業;

 

3

 

 

單戶住宅供應和/或需求減少,無法獲取更多樣板房,以及購買此類房產的競爭加劇;

 

 

恐怖主義襲擊或行動,以及與信息技術和網絡安全攻擊相關的風險,機密信息丟失及其他相關業務中斷風險;

 

 

未能繼續符合REIT資格;

 

 

任何法律程序的不利結果;

 

 

影響我們業務的法律、規則和法規的變化;

 

  如果我們存入資金的任何銀行機構最終破產,我們可能會失去超過聯邦保險水平的任何存入資金,這可能會減少我們可用於分配或投資的現金,並可能導致我們價值的下降。

   

 

我們可能無法符合納斯達克資本市場("納斯達克")的繼續上市要求,可能導致我們的普通股被除牌,這可能會影響我們普通股的市場價格和流動性,並降低我們籌集資本的能力;

     
 

激進股東的行動可能導致我們承擔重大成本,分散管理層的注意力和資源,並對我們的業務產生不利影響;和

     
 

在我們的風險因素中討論的其他風險和不確定性 年度報告在於2023年12月31日結束,於2024年4月16日提交給SEC的10-K/A表格中討論的風險因素.

 

 

4

 

第一部分 — 財務信息

 

項目1.基本報表

 

presidio property trust, inc.及其子公司

合併資產負債表

 

  

9月30日,

  

2023年12月31日,

 
  2024  2023 
  

(未經審計)

     

資產

        

房地產資產和租賃無形資產:

        

土地

 $17,525,059  $21,660,644 

建築物和改善

  116,284,225   133,829,416 

租戶改進

  18,493,786   17,820,948 

租賃無形資產

  3,475,531   4,110,139 

房地產資產和用於投資的租賃無形資產的成本

  155,778,601   177,421,147 

累計折舊及攤銷費用

  (37,710,504)  (38,725,356)

房地產資產和用於投資的租賃無形資產,淨值

  118,068,097   138,695,791 

資產負債表中持有待售房地產資產淨額

  13,347,113   5,459,993 

房地產業資產淨值

  131,415,210   144,155,784 

其他資產:

        

現金、現金等價物和受限制的現金

  7,199,448   6,510,428 

推遲租賃成本,淨額

  1,582,820   1,657,055 

商譽

  1,574,000   1,574,000 

投資於Conduit Pharmaceuticals市場證券(見注2和9)

  481,219   18,318,521 

遞延所得稅資產

  346,762   346,762 

其他資產淨額(見注6)

  3,245,771   3,400,088 

其他資產總計

  14,430,020   31,806,854 

資產總計

 $145,845,230  $175,962,638 

負債和股東權益

        

負債:

        

按揭貸款,淨額

 $91,758,522  $103,685,444 

與待售房地產相關的應付抵押借據淨額

  10,560,697   4,027,829 

應付抵押借據總淨額

  102,319,219   107,713,273 

應付賬款及應計負債

  3,497,588   4,770,845 

應計房地產稅

  1,656,919   1,953,087 

應付股息

  195,310   174,011 

租賃負債,淨額

  70,122   16,086 

低於市場租賃淨額

  9,535   13,266 

總負債

  107,748,693   114,640,568 
         

承諾和 contingencies(參見注釋10)

          

股東權益:

        

D系列優先股,$0.01 每股面值; 1,000,000 授權股份數; 1,000,000 shares issued and outstanding (liquidation preference $25.00 截至2024年9月30日,每股資產 890,946 截至2023年12月31日已發行和流通的股份

  10,000   8,909 

A系列普通股,$0.01 每股面值, 100,000,000 授權股份數; 12,369,645 股數和 12,265,061 截至2024年9月30日和2023年12月31日,分別發行和流通的股份

  123,696   122,651 

追加實收資本

  185,712,362   182,331,408 

分紅派息和累積虧損

  (156,309,316)  (131,508,785)

非控股權益前的股東權益合計

  29,536,742   50,954,183 

非控股權益

  8,559,795   10,367,887 

總股本

  38,096,537   61,322,070 

負債和所有者權益總計

 $145,845,230  $175,962,638 

 

請參見合併基本報表的註釋

 

5

 

 

presidio property trust, inc.及其子公司

截至2020年6月30日和2019年6月30日三個月和六個月的營業額

(未經審計)

 

   

截至9月30日三個月的情況

   

截至9月30日九個月期間

 
   

2024

   

2023

   

2024

   

2023

 

營業收入:

                               

租金收入

  $ 4,474,833     $ 4,262,790     $ 13,156,881     $ 12,534,431  

費用和其他收入

    248,541       221,384       943,095       615,107  

總營業收入

    4,723,374       4,484,174       14,099,976       13,149,538  

成本和費用:

                               

租賃運營成本

    1,598,015       1,478,479       4,654,087       4,452,628  

一般和行政

    1,629,919       1,635,610       5,917,286       5,413,413  

折舊和攤銷

    1,455,882       1,351,705       4,158,270       4,054,109  

房地產資產減值

    697,146             893,939        

總成本和費用

    5,380,962       4,465,794       15,623,582       13,920,150  

其他收入(費用):

                               

利息支出 - 抵押貸款

    (1,473,528 )     (1,375,199 )     (4,514,579 )     (3,579,381 )

利息和其他收入,淨額

    5,263       254,486       15,116       1,394,687  

房地產銷售收益,淨額

    361,151       757,285       3,191,149       2,294,574  

在Conduit Pharmaceuticals的可交易證券中淨損失(見腳註9)

    (3,932,770 )     (17,682,154 )     (17,821,437 )     (17,682,154 )

SPAC解散收益(見腳註9)

          40,321,483             40,321,483  

所得稅(收益)費用

    (6,911 )     (134,620 )     (167,496 )     (632,147 )

總其他(收益)費用,淨額

    (5,046,795 )     22,141,281       (19,297,247 )     22,117,062  

淨利潤(損失)

    (5,704,383 )     22,159,661       (20,820,853 )     21,346,450  

減:歸屬於非控股權益的收入

    (355,153 )     (673,279 )     (2,328,386 )     (2,155,212 )

歸屬於presidio property trust, inc.股東的淨利潤(損失)

  $ (6,059,536 )   $ 21,486,382     $ (23,149,239 )   $ 19,191,238  

減:優先股D系列分紅派息

    (585,930 )     (527,873 )     (1,651,293 )     (1,595,606 )

歸屬於presidio property trust公司普通股股東的淨利潤(虧損)

  $ (6,645,466 )   $ 20,958,509     $ (24,800,532 )   $ 17,595,632  
                                 

歸屬於presidio property trust公司普通股股東的每股淨利潤(虧損):

                               

基本和稀釋

  $ (0.53 )   $ 1.77     $ (2.00 )   $ 1.49  
                                 

基本及稀釋後的普通股加權平均發售價

    12,476,567       11,851,343       12,399,798       11,841,847  

 

請參閱並注意基本報表註釋

 

6

 

 

presidio property trust, inc.及其子公司

股東權益變動表

截至2024年9月30日和2023年第三季度及九個月

(未經審計)

 

                                   

額外的

   

分紅派息和

   

總計

   

非-

         
   

優先股系列D

   

普通股

   

實收股本

   

累計

   

股東權益

   

控股

   

總計

 
   

股份

   

金額

   

股份

   

金額

   

資本

   

損失

   

股權

   

利益

   

股權

 

2023年12月31日餘額

    890,946     $ 8,909       12,265,061     $ 122,651     $ 182,331,408     $ (131,508,785 )   $ 50,954,183     $ 10,367,887     $ 61,322,070  

淨利潤(虧損)

                                  (5,241,663 )     (5,241,663 )     1,503,868       (3,737,795 )

向D系列優先股股東支付分紅

                                  (522,032 )     (522,032 )           (522,032 )

超過收到的出資額的分配

                                              (1,603,357 )     (1,603,357 )

受限股份爲基礎的補償

                            317,077             317,077             317,077  

發行股份補償A類普通股

                164,078       1,640       223,204             224,844             224,844  

2024 年 3 月 31 日餘額

    890,946     $ 8,909       12,429,139     $ 124,291     $ 182,871,689     $ (137,272,480 )   $ 45,732,409     $ 10,268,398     $ 56,000,807  

淨利潤(虧損)

                                  (11,848,040 )     (11,848,040 )     469,365       (11,378,675 )

向D類優先股股東派發分紅

                                  (543,331 )     (543,331 )           (543,331 )

分配

                                              (1,002,976 )     (1,002,976 )

發行優先股D類優先股,扣除發行成本淨額

    109,054       1,091                   1,194,764             1,195,855             1,195,855  

受限股份爲基礎的補償

                            343,108             343,108             343,108  

以成本回購A系列普通股

                (10,446 )     (104 )     (7,509 )           (7,613 )           (7,613 )

餘額,2024年6月30日

    1,000,000     $ 10,000       12,418,693     $ 124,187     $ 184,402,052     $ (149,663,851 )   $ 34,872,388     $ 9,734,787     $ 44,607,175  

淨利潤(虧損)

                                  (6,059,536 )     (6,059,536 )     355,153       (5,704,383 )

向D系列優先股東支付分紅派息

                                  (585,929 )     (585,929 )           (585,929 )

分配

                                              (477,566 )     (477,566 )

基於受限制的股票的補償

                            347,021             347,021             347,021  

發行A系列普通股

                78,215       782       1,051,797             1,052,579       (1,052,579 )      

以成本回購A系列普通股

                (127,263 )     (1,273 )     (88,508 )           (89,781 )           (89,781 )

餘額,2024年9月30日

    1,000,000     $ 10,000       12,369,645     $ 123,696     $ 185,712,362     $ (156,309,316 )   $ 29,536,742     $ 8,559,795     $ 38,096,537  

 

7

 

                                   

額外的

   

分紅派息和

   

總計

   

非-

         
   

優先股系列D

   

普通股

   

實收股本

   

累計

   

股東權益

   

控股

   

總計

 
   

股份

   

金額

   

股份

   

金額

   

資本

   

損失

   

股權

   

利益

   

股權

 

2022年12月31日餘額

    913,987     $ 9,140       11,807,893     $ 118,079     $ 182,122,213     $ (138,341,750 )   $ 43,907,682     $ 9,013,446     $ 52,921,128  

淨利潤(虧損)

                                  (995,540 )     (995,540 )     387,081       (608,459 )

分紅派息給A股普通股東

                                  (287,655 )     (287,655 )           (287,655 )

分紅派息給D系列優先股東

                                  (535,448 )     (535,448 )           (535,448 )

超過收到的貢獻額的分配

                                              (518,642 )     (518,642 )

重新衡量SPAC股份的贖回價值

                            (158,900 )           (158,900 )           (158,900 )

SPAC贖回的滯納稅款

                            (1,140,683 )           (1,140,683 )           (1,140,683 )

受限股票爲基礎的補償

                                    232,106               232,106             232,106  

回購D系列優先股,按成本計量

    (386 )     (4 )                 (6,943 )           (6,947 )           (6,947 )

發放以股票爲基礎的補償普通股

                27,371       274       28,466             28,740             28,740  

2023年3月31日的結存

    913,601     $ 9,136       11,835,264     $ 118,353     $ 181,076,259     $ (140,160,393 )   $ 41,043,355     $ 8,881,885     $ 49,925,240  

淨利潤(虧損)

                                  (1,299,604 )     (1,299,604 )     1,094,852       (204,752 )

向A類普通股股東支付的分紅

                                  (302,496 )     (302,496 )           (302,496 )

向D類優先股股東支付的分紅

                                  (532,285 )     (532,285 )           (532,285 )

超額分配的分紅

                                              (1,442,668 )     (1,442,668 )

SPAC股份重新計量爲贖回價值

                            (247,094 )           (247,094 )           (247,094 )

限制性股票相關的報酬

                                228,657             228,657             228,657  

以成本回購D類優先股

    (12,226 )     (122 )                 (204,803 )           (204,925 )           (204,925 )

普通股解禁

                14,446       144       50,855             50,999             50,999  

餘額,2023年6月30日

    901,375     $ 9,014       11,849,710     $ 118,497     $ 180,903,874     $ (142,294,778 )   $ 38,736,607     $ 8,534,069     $ 47,270,676  

淨利潤

                                  21,486,382       21,486,382       673,279       22,159,661  

限制性股票的授予

                10,016       100       17,027             17,127             17,127  

向A類普通股股東支付的分紅派息

                                  (302,495 )     (302,495 )           (302,495 )

向D類優先股股東支付的分紅派息

                                  (527,873 )     (527,873 )           (527,873 )

SPAC脫離共同控制前對應納稅的扭轉

                            1,140,683             1,140,683             1,140,683  

基於限制性股票的薪酬

                                270,564             270,564             270,564  

按成本回購D類優先股

    (2,435 )     (25 )                 (38,873 )           (38,898 )           (38,898 )

超額分配收到的貢獻

                                              (1,052,521 )     (1,052,521 )

餘額,2023年9月30日

    898,940     $ 8,989       11,859,726     $ 118,597     $ 182,293,275     $ (121,638,764 )   $ 60,782,097     $ 8,154,827     $ 68,936,924  

 

請參閱並注意基本報表註釋

 

8

 

 

普雷西迪奧房地產信託公司及其子公司

合併現金流量表

(未經審計)

 

   

截至9月30日九個月期間

 
   

2024

   

2023

 

經營活動現金流量:

               

淨利潤(虧損)

  $ (20,820,853 )   $ 21,346,450  

重分類和其他項目

               

折舊和攤銷

    4,158,270       4,054,109  

保修準備金

    1,232,050       828,193  

壞賬費用

          27,729  

房地產資產出售收益,淨額

    (3,191,149 )     (2,294,574 )

SPAC投資去合併的收益

          (40,321,483 )

Conduit Pharmaceuticals公允價值可交易證券的淨損失

    17,821,437       17,682,154  

可交易證券的淨損失(收益)

    560       (169,530 )

SPAC信託帳戶公允價值的淨收益

          (1,209,542 )

房地產資產減值

    893,939        

融資成本攤銷

    286,491       263,863  

低於市場租賃的攤銷

    (3,731 )     (3,731 )

遞延租賃成本的攤銷

    5,808       5,808  

直線租金調整

    (113,491 )     (280,619 )

運營資產和負債的變化:

               

其他資產

    158,524       (92,877 )

應付賬款及應計負債

    (1,172,517 )     (472,157 )

特別目的收購公司(SPAC)的應付賬款和應計負債

          652,577  

應計房地產稅

    (296,168 )     (373,343 )

經營活動中提供的淨現金流量(流出)

    (1,040,830 )     (356,973 )

投資活動現金流量:

               

房地產業收購

    (9,729,351 )     (13,715,923 )

對建築物及租戶改善的增加

    (1,939,641 )     (1,966,868 )

投資於可交易證券

          (2,083,328 )

出售有市場流通的證券收益

    60,467       2,302,456  

將SPAC IPO收益投資於信託帳戶

          (624,998 )

從信託帳戶提取SPAC稅款

          832,480  

從信託帳戶提取SPAC股份贖回款

          137,157,011  

房地產業銷售獲利,淨額

    22,273,254       7,113,065  

投資活動提供的淨現金流量

    10,664,729       129,013,895  

融資活動的現金流:

               

抵押貸款應付款的收益,扣除發行成本

    13,602,291       13,400,934  

償還抵押借款

    (18,900,440 )     (7,885,953 )

對非控股權益的分配,淨額

    (3,083,899 )     (3,013,831 )

贖回SPAC股份

          (137,157,011 )

發行D系列優先股,扣除發行成本

    1,195,855        

按成本回購A系列普通股

    (97,394 )      

按成本回購D系列優先股

          (250,770 )

向D系列優先股股東支付的分紅派息

    (1,651,292 )     (1,595,606 )

向A系列普通股股東支付的分紅派息

          (892,646 )

融資活動所使用的淨現金

    (8,934,879 )     (137,394,883 )

經營性現金流淨額

    689,020       (8,737,961 )

期初現金、現金等價物及受限制的現金餘額

    6,510,428       16,516,725  

期末現金、現金等價物及受限制的現金餘額

  $ 7,199,448     $ 7,778,764  

現金流信息的補充披露:

               

應付利息-抵押貸款票據

  $ 4,064,414     $ 3,637,980  

支付了來自前一年的建築和租戶改進的附加費用

  $ 295,567     $  

所得稅已付款項

  $ 71,546     $  

非現金投資活動:

               

Conduit Pharmaceuticals的私人warrants

  $ 642,600     $  

非現金融資活動:

               

發行A系列普通股以獲得少數股權

  $ 1,052,579     $  

應付賬款中包含的未付建築和租戶改進附加費用

  $ 30,204     $ 850,918  

應付分紅派息 - 普通股 A系列

  $     $ 302,495  

應付分紅派息 - 優先股 D系列

  $ 195,310     $ 175,758  

 

請參閱並注意基本報表註釋

 

9

 

presidio property trust, inc.及其子公司

合併財務報表註釋(未經審計)

2024年9月30日

 

1. 組織

 

組織。Presidio Property Trust, Inc.(「我們」、「我們的」、「我們」或「公司」)是一家內部管理的股權房地產投資信託(「REIT」),在辦公、工業、零售和樣板房產上擁有資產。我們於1999年9月28日在加利福尼亞州註冊成立, 1999年9月28日, 並根據 2010年8月, 我們重新註冊爲馬里蘭州公司。 在2017年10月, 我們將公司名稱從「NetREIt, Inc.」更改爲「Presidio Property Trust, Inc.」通過Presidio Property Trust, Inc.及其子公司和合作夥伴,我們擁有 12 擁有的商業物業的有償權益, 我們作爲普通合夥人、成員和/或經理在各種附屬公司中擁有的部分權益,以及一個特殊目的收購公司(直到 2023年9月) 如下所述。

 

公司或其關聯公司在這些合併基本報表覆蓋的期間內運營以下合作關係: 一份 在這些合併基本報表涵蓋的期間內:

 

 該公司是唯一的普通合夥人和有限合夥人在家善控股 有限合夥關係(NetREIt Palm Self-Storage LP和NetREIt Casa Grande LP),兩者在 2024年9月30日年,持有擁有生產收入的房地產的實體的所有權利。公司稱這些實體爲「NetREIt合作關係」。
   
 

該公司在有限合夥關係中擔任普通合夥人和有限合夥人 有限合夥關係,購買樣板房並將其作爲商業租戶租回給建造房屋的公司(Dubose Model Home Investors #202, LP,杜波斯模型家善控股 #203, LP,杜波斯模型家善控股 #204, LP,杜波斯模型家善控股 #205, LP,杜波斯模型家善控股 #206, LP和杜波斯模型家善控股 #207, LP). 公司將這些實體統稱爲"模型家善股東關係"。

 

公司已確定其擁有少於的有限合夥企業 100% 應納入公司的合併基本報表,因爲公司指揮其活動並控制這些有限合夥企業。

 

我們已選擇根據修訂後的《稅法》第,作爲房地產投資信託基金(REIT)進行納稅。 856 通過 860 內部收入法典的第...的 1986, 爲了保持我們作爲REIT的資格,我們必須向股東分配至少 90% 我們的REIT應稅收入,並滿足《稅法》規定的與經營結果、資產持有、分配水平和股權多樣性等相關的其他各種要求。如果我們保持REIT的納稅資格,我們通常會 在測試商譽減值時,公司可以選擇 針對從REIT合格活動中獲得的利潤,向股東分配的收益,需支付公司層面的所得稅。如果我們在任何納稅年度未能保持REIT的資格,並無法利用《稅法》中規定的某些節稅條款,所有應稅收入將按常規公司稅率,包含任何適用的替代最低稅,繳納聯邦所得稅。我們還需繳納某些州和地方的所得稅。

 

我們與我們的實體一起 一份 已選擇將某些子公司視爲可納稅的REIT子公司(「TRS」)以用於聯邦所得稅目的。我們進行的某些活動必須由TRS進行,例如爲我們的商業租戶提供非常規服務,並持有我們無法直接持有的資產。TRS應繳納聯邦和州所得稅。公司已經得出結論,基本報表中存在着 沒有 重大的不確定稅務立場需要在財務報表中確認。公司及其附屬公司均尚未被任何稅收司法管轄區針對稅務立場徵收任何重大利息或罰款。

 

流動性。公司預期的未來流動性來源 可能 包括現有現金和現金等價物、運營現金流、現有抵押貸款再融資、未來房地產銷售、新借款以及股權或債務證券的出售。未來的資本需求包括償還現有借款、維護現有房產、爲租戶改善商業建築提供資金、支付租賃佣金(視情況而定) 由貸款人持有的儲備存款支付),以及向股東支付的股息。該公司還在尋求可能產生收入和實現長期收益的投資,以便向我們的股東支付股息。爲了確保我們能夠有效地實現這些目標,我們會定期審查我們的流動性需求,並持續評估所有潛在的流動性來源。我如有必要,公司 可能 根據信貸環境尋求其他短期流動性替代方案,例如過渡貸款、房地產再融資貸款或銀行信貸額度。參見備註 11 股東權益,了解有關證券銷售的更多信息。

 

10

 

短期流動性需求包括支付我們的當前運營成本,滿足現有抵押貸款的償債要求,完成 商業大樓的任何改進,支付租賃佣金,分配給非控制權益人,並根據需要向股東支付分紅派息。未來應付的按揭貸款本金,約爲20242025 總額。 $11.7 百萬和$37.5 百萬,分別。其中$2.3 百萬中,我們根據普通股的成交量加權平均股價(扣除折扣),額外獲得了 2024 and $8.9 百萬中 2025 與樣板房物業相關。請參閱注 7. 有關t的抵押借款註釋額外信息到期的Dakota Center貸款。 2024年7月6日。管理團隊預計某些示範房產可以出售,並且基礎的抵押借據將會通過銷售收入償還,而其他抵押借據可以進行再融資,正如公司過去一直能夠做到的那樣在所有示範房產上。額外的本金還款將通過經營活動產生的現金流進行。

 

隨着公司的繼續運營, 可能 再融資或尋求額外融資。但是,可能有 保證任何此類再融資或額外融資將以可接受的條件提供給公司(如果有的話)。如果發生的事件或情況使公司確實如此 獲得額外資金,很可能需要減少計劃和/或某些全權支出,這可能會對公司實現其預期業務目標的能力產生重大不利影響。管理層認爲,手頭營運資金與爲商業和模型住房抵押貸款再融資的能力相結合,將至少在下一年爲運營提供資金 十二 自這些未經審計的中期財務報表發佈之日起的幾個月。

 

自成立以來,公司一直擔任前特殊收購公司Murphy Canyon Acquisition Corp.("Murphy Canyon"或"SPAC")的贊助商。 2021年10月 而且公司的某些高管和董事也擔任SPAC的高管和董事。在 2023年9月22日, 當Murphy Canyon與康德製藥有限公司("Conduit Pharma")完成業務合併,並將其更名爲Conduit Pharmaceuticals Inc.("Conduit")時。在業務合併之前,公司擁有SPAC流通普通股的約 65%。在業務合併完成後,SPAC的B類普通股轉換爲A類普通股,A類普通股再重新分類爲Conduit普通股的一種類別。由於業務合併,公司被髮行了(i) 3,306,250 Conduit的普通股,因爲SPAC的B類普通股轉換爲SPAC的A類普通股,然後重新分類爲Conduit普通股的股份,(ii) 754,000 Conduit普通股的股份,這些在業務合併之前是SPAC的A類普通股,以及(iii)用於購買的私人認股權證warrants 754,000 Conduit普通股的股份,在業務合併之前是購買權證 754,000 SPAC的A類普通股的股份。同時,在業務合併中,Conduit Pharma的股東和債權人發行了 65,000,000 Conduit普通股的股份。在業務合併完成後,公司將Conduit普通股和購買權證轉讓給SPAC的獨立董事作爲服務的補償。因此,公司在業務合併完成後擁有約 45,000 Conduit普通股和購買權證 45,000 Conduit普通股的股份轉讓給SPAC的獨立董事作爲他們服務的補償。因此,公司擁有大約 6.5%的Conduit股份。與業務合併相關,公司的軍官和董事們,他們還兼任SPAC的軍官和董事,從SPAC辭職,除了公司的前首席財務官辭去了公司的職務。有關更多信息,請參見附註 9. 有關對Conduit製藥公司的投資的額外信息。

 

 

2. SIGNIFICANT ACCOUNTING POLICIES

 

There have been no significant changes to the Company’s accounting policies since it filed its audited financial statements in the 2023 year end Annual Report. For further information about the Company’s accounting policies, refer to the Company’s consolidated financial statements and notes thereto for the year ended December 31, 2023, included in the Company’s 2023 year end Annual Report.

 

Basis of Presentation. The accompanying consolidated financial statements have been prepared by the Company's management in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and the instructions to Form 10-Q and Article 8 of Regulation S-X. Certain information and footnote disclosures required for annual consolidated financial statements have been excluded pursuant to rules and regulations of the SEC. In the opinion of management, the accompanying consolidated financial statements reflect all adjustments of a normal and recurring nature that are considered necessary for a fair presentation of our financial position as of September 30, 2024, and  December 31, 2023, as well as results of our operations, and cash flows as of, and for the nine months ended September 30, 2024 and 2023, respectively. However, the results of operations for the interim periods are not necessarily indicative of the results that may be expected for the year ending December 31, 2024, due to real estate market fluctuations, available mortgage lending rates and other unknown factors. These consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the 2023 year end Annual Report. The consolidated balance sheet as of December 31, 2023 has been derived from the audited consolidated financial statements included in the 2023 year end Annual Report. 

 

11

 

Principles of Consolidation. The accompanying consolidated financial statements include the accounts of Presidio Property Trust, Inc. and its subsidiaries, NetREIT Advisors, LLC and Dubose Advisors LLC (collectively, the “Advisors”), and NetREIT Dubose Model Home REIT, Inc. The consolidated financial statements also include the results of the NetREIT Partnerships and the Model Home Partnerships.  As used herein, references to the “Company” include references to Presidio Property Trust, Inc., its subsidiaries, and the partnerships. All significant intercompany balances and transactions have been eliminated in consolidation.

 

The consolidated financial statements also include the accounts of (a) Murphy Canyon up until September 22, 2023, when it completed its business combination.  Murphy Canyon was a special purpose acquisition company ("SPAC") for which we served as the financial sponsor (as described herein), and which was deemed to be controlled by us as a result of our 65% equity ownership stake, the overlap of three of our executive officers as executive officers of Murphy Canyon, and significant influence that we exercised over the funding and acquisition of new operations for an initial business combination (see Note 2, Variable Interest Entity). All intercompany balances, prior to deconsolidation and loss of control on September 22, 2023, have been eliminated in consolidation.

 

The Company classifies the noncontrolling interests in the NetREIT Partnerships as part of consolidated net (loss) income in 2024 and 2023 and has included the accumulated amount of noncontrolling interests as part of equity since inception in February 2010. If a change in ownership of a consolidated subsidiary results in loss of control and deconsolidation, any retained ownership interest will be remeasured, with the gain or loss reported in the consolidated statements of operations. Management has evaluated the noncontrolling interests and determined that they do not contain any redemption features.

 

Use of Estimates. The consolidated financial statements were prepared in conformity with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates include, private warrants, the allocation of purchase price paid for property acquisitions between the components of land, building and intangible assets acquired including their useful lives, valuation of long-lived assets, and the allowance for doubtful accounts, which is based on an evaluation of the tenants’ ability to pay. Actual results could differ from those estimates.

 

Real Estate Assets and Lease Intangibles. Land, buildings and improvements are recorded at cost, including tenant improvements and lease acquisition costs (including leasing commissions, space planning fees, and legal fees). The Company capitalizes any expenditure that replaces, improves, or otherwise extends the economic life of an asset, while ordinary repairs and maintenance are expensed as incurred. The Company allocates the purchase price of acquired properties between the acquired tangible assets and liabilities (consisting of land, buildings, tenant improvements, and long-term debt) and identified intangible assets and liabilities (including the value of above-market and below-market leases, the value of in-place leases, unamortized lease origination costs and tenant relationships), in each case based on their respective fair values.

 

The Company allocates the purchase price to tangible assets of an acquired property based on the estimated fair values of those tangible assets, assuming the property was vacant. Estimates of fair value for land, building and building improvements are based on many factors, including, but not limited to, comparisons to other properties sold in the same geographic area and independent third-party valuations. In estimating the fair values of the tangible assets, intangible assets, and liabilities acquired, the Company also considers information obtained about each property as a result of its pre‑acquisition due diligence, marketing and leasing activities.

 

The value allocated to acquired lease intangibles is based on management’s evaluation of the specific characteristics of each tenant’s lease. Characteristics considered by management in allocating these values include, but are not limited, to the nature and extent of the existing business relationships with the tenant, growth prospects for developing new business with the tenant, the remaining term of the lease, the tenant’s credit quality, and other factors.

 

The value attributable to the above-market or below-market component of an acquired in-place lease is determined based upon the present value (using a market discount rate) of the difference between (i) the contractual rents to be paid pursuant to the lease over its remaining term, and (ii) management’s estimate of rents that would be paid using fair market rates over the remaining term of the lease. The amounts allocated to above or below-market leases are amortized on a straight-line basis as an increase or reduction of rental income over the remaining non-cancelable term of the respective leases. Amortization of above and below-market rents resulted in a net increase in rental income of approximately $1,244 and $3,731 in each period for the three and nine months ended September 30, 2024 and for the three and nine months ended September 30, 2023.  

 

The value of in-place leases and unamortized lease origination costs are amortized to expenses over the remaining term of the respective leases, which range from less than a year to ten years. The amount allocated to acquired in-place leases is determined based on management’s assessment of lost revenue and costs incurred for the period required to lease the “assumed vacant” property to the occupancy level when purchased.

 

12

 

The amount allocated to unamortized lease origination costs is determined by what the Company would have paid to a third-party to secure a new tenant reduced by the expired term of the respective lease. The amount allocated to tenant relationships is the benefit resulting from the likelihood of a tenant renewing its lease. Amortization expense related to these assets was approximately $4,382 and $13,145 during each period for the three and nine months ended September 30, 2024 and for the three and nine months ended September 30, 2023.

 

Deferred Leasing Costs. Costs incurred in connection with successful property leases are capitalized as deferred leasing costs and amortized to leasing commission expense on a straight-line basis over the terms of the related leases which generally range from one to five years. Deferred leasing costs consist of third-party leasing commissions. Management re-evaluates the remaining useful lives of leasing costs as the creditworthiness of the tenants and economic and market conditions change. If management determines the estimated remaining life of the respective lease has changed, the amortization period is adjusted. At September 30, 2024 and  December 31, 2023, the Company had net deferred leasing costs of approximately $1.6 million and $1.7 million, respectively. Total amortization expense for the three and nine months ended September 30, 2024, was approximately $125,302 and $369,401, respectively. Total amortization expense for the three and nine months ended September 30, 2023, was approximately $123,408 and $351,559, respectively.

 

Cash Equivalents and Restricted Cash. At September 30, 2024 and December 31, 2023, we had approximately $7.2 million and $6.5 million in cash, cash equivalents and restricted cash, respectively, of which approximately $3.5 million and $3.7 million represented restricted cash, respectively.  The Company considers all short-term, highly liquid investments that are both readily convertible to cash and have an original maturity of three months or less at the date of purchase to be cash equivalents. Items classified as cash equivalents include money market funds and short-term bonds. Cash balances in individual banks may exceed the federally insured limit of $250,000 by the Federal Deposit Insurance Corporation (the "FDIC"). No losses have been experienced related to such accounts. At September 30, 2024 and  December 31, 2023, the Company had approximately $1.3 million and $0.7 million, respectively, in deposits in financial institutions that exceeded the federally insurable limits. Restricted cash consists of cash held in escrow by lenders pursuant to certain lender agreements, which are for payment of property taxes, insurance, leasing costs, future debt payments, and capital expenditures. 

 

Real Estate Held for Sale and Discontinued Operations. We generally reclassify assets to "held for sale" when the disposition has been approved, it is available for immediate sale in its present condition, we are actively seeking a buyer, and the disposition is considered probable within one year.  Additionally, real estate sold during the current period is classified as “real estate assets held for sale” for all prior periods presented in the accompanying consolidated financial statements. Mortgage notes payable related to the real estate sold during the current period are classified as “mortgage notes payable related to properties held for sale” for all prior periods presented in the accompanying consolidated financial statements. Additionally, we record the operating results related to real estate that has been disposed of as discontinued operations for all periods presented if the operations have been eliminated and represent a strategic shift and we will not have any significant continuing involvement in the operations of the property following the sale.  As of September 30, 2024, two commercial properties, Union Town Center and Research Parkway, met the criteria to be classified as "held for sale", and 5 model homes were classified as "held for sale".

 

Deferred Offering Costs. Deferred offering costs represent legal, accounting and other direct costs related to our offerings. As of September 30, 2024 and December 31, 2023, we have incurred approximately zero and $5,000, respectively, in deferred offering costs as of the end of each period related to our registration statement on Form S-3. 

 

Impairments of Real Estate Assets. We regularly review for impairment on a property-by-property basis. Impairment is recognized on a property held for use when the expected undiscounted cash flows for a property are less than the carrying amount at which time the property is written-down to fair value. The calculation of both discounted and undiscounted cash flows requires management to make estimates of future cash flows, including, but not limited to, revenues, operating expenses, required maintenance and development expenditures, market conditions, demand for space by tenants and rental rates over long periods. Since our properties typically have a long life, the assumptions used to estimate the future recoverability of carrying value requires significant management judgment. Actual results could be significantly different from the estimates. These estimates have a direct impact on net income because recording an impairment charge results in a negative adjustment to net income. The evaluation of anticipated cash flows is highly subjective and is based in part on assumptions regarding future occupancy, rental rates and capital requirements that could differ materially from actual results in future periods. Properties held for sale are recorded at the lower of the carrying amount or the expected sales price less costs to sell. Although our strategy is to hold our properties over the long-term, if our strategy changes or market conditions otherwise dictate an earlier sale date, an impairment loss may be recognized to reduce the property to fair value and such loss could be material.

 

We review the carrying value of each of our real estate properties regularly to determine if circumstances indicate an impairment in the carrying value of these investments exists. During the three and nine months ended September 30, 2024, we recognized non-cash impairment charges of approximately $0.7 million and $0.9 million, respectively, with approximately $0.2 million related to model homes and approximately $0.7 million related to our Dakota Center property.  

 

13

 

The new impairment charges for the model homes, during the three months ended  September 30, 2024, reflects the estimated sales prices for these specific model homes in October and  November 2024 as a result of an abnormally short hold period, less than two years, on model homes purchased in 2022.  The total impairment chargers on model homes during the three and nine months ended September 30, 2024 was approximately $41,656 and $238,449, respectively. The builder changed their product style in the neighborhoods where these model homes are located, in Texas, after we had purchased the homes.  We do not believe these losses are indicative of our overall model home portfolio.  As noted below in footnote 3 - Recent Real Estate Transactions, during the nine months ended September 30, 2024, we sold 46 model homes for approximately $22.3 million, net of sales costs, and the Company recognized a net gain of approximately $3.2 million.  The Company did not recognize a non-cash impairment to our real estate assets during the three and nine months ended September 30, 2023.

 

The Dakota Center property impairment of approximately $0.7 million, is related to the maturing of our non-recourse real estate loan in July 2024 and the Company not being able to come to an agreement with the current lender on a modification or extension.  In October 2024, we and the lender agreed to offer the property for sale with net proceeds being applied to pay off the loan balance, accrued interest and fees.  Excess proceeds, if any, will go to the Company, while a shortfall of proceeds from the sale to pay down the lender will not be the Company's responsibility.

 

Fair Value Measurements.  Certain assets and liabilities are required to be carried at fair value, or if long-lived assets are deemed to be impaired, to be adjusted to reflect this condition. The guidance requires disclosure of fair values calculated under each level of inputs within the following hierarchy:

 

 

Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;

 

 

Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

 

 

Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable.

 

When available, we utilize quoted market prices from independent third-party sources to determine fair value and classify such items in Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require us to make a significant adjustment to derive a fair value measurement.

 

Additionally, in an inactive market, a market price quoted from an independent third-party may rely more on models with inputs based on information available only to that independent third-party. When we determine the market for a financial instrument owned by us to be illiquid or when market transactions for similar instruments do not appear orderly, we use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) and establish a fair value by assigning weights to the various valuation sources. As of September 30, 2024, we did not hold any marketable securities, excluding our investments in Conduit's common stock and common stock warrants.  As of  December 31, 2023, our marketable securities (excluding our investments in Conduit's common stock and common stock warrants), held at a third party broker, presented on the consolidated balance sheets within other assets were measured at fair value using Level 1 market prices and totaled approximately $45,149, with a cost basis of approximately  $40,315. There were no financial liabilities measured at fair value as of September 30, 2024 and December 31, 2023.

 

On April 22, 2024, the Company entered into a lockup agreement with Conduit pursuant to which the Company agreed not to transfer or sell 2,700,000 of its 4,015,250 shares of Conduit common stock for a period of one year.  In consideration for entering into the lockup agreement, Conduit issued the Company a warrant ("Private CDT Warrants") to purchase 540,000 shares of common stock at an exercise price of $3.12 per share, with a two year term and exercisable one year after the date of issue.  The Private CDT Warrants meet the ASC 321, Investments - Equity Securities ("ASC 321") scope exception for derivative instruments and are accounted for as a derivative under ASC 815, Derivatives and Hedging ("ASC 815"). As such, the Private CDT Warrants were recorded at fair value on the date of issuance and subsequently measured at fair value each period, with changes in fair value reported in gain or loss on Conduit Pharmaceuticals marketable securities.  As of April 22, 2024, the Private CDT Warrants were valued at $891,000 based on a Level 3 fair value measurement.  As of  September 30, 2024, the Private CDT Warrants fair value was adjusted to zero, and is included in the total Investment in Conduit Pharmaceuticals marketable securities on the September 30, 2024 consolidated balance sheet.  Our investments in Conduit's common stock (CDT) and public common stock warrants (CDTTW) presented on the consolidated balance sheets were measured at fair value using Level 1 market prices, taking into account the adoption of ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, and totaled approximately $0.5 million as of September 30, 2024. The combined value of our Investment in Conduit Pharmaceuticals marketable securities, including the Private CDT Warrants, totaled $0.5 million as of September 30, 2024. Our investments in Conduit's common stock and public common stock warrants presented on the consolidated balance sheet were measured at fair value using Level 1 market prices as of  December 31, 2023, and totaled approximately $18.3 million.  The adjustments to the fair value of our investment in Conduit Pharmaceuticals marketable securities are recorded in net loss in Conduit Pharmaceuticals marketable securities on our consolidated statement of operations.

 

14

 

Earnings per share (EPS). The EPS on common stock has been computed pursuant to the guidance in FASB ASC Topic 260, Earnings Per Share.  The guidance requires the classification of the Company’s unvested restricted stock, which contains rights to receive non-forfeitable dividends, as participating securities requiring the two-class method of computing net income per share of common stock.  In accordance with the two-class method, earnings per share have been computed by dividing the net income less net income attributable to unvested restricted shares by the weighted average number of shares of common stock outstanding less unvested restricted shares. Diluted earnings per share is computed by dividing net income by the weighted average shares of common stock and potentially dilutive securities outstanding in accordance with the treasury stock method.

 

Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

 

  

For the Three Months Ended September 30,

  

For the Nine Months Ended September 30,

 
  

2024

  

2023

  

2024

  

2023

 
                 

Common Stock Warrants

  2,000,000   2,000,000   2,000,000   2,000,000 

Placement Agent Warrants

  80,000   80,000   80,000   80,000 

Series A Warrants

  14,450,069   14,450,069   14,450,069   14,450,069 

Unvested Restricted Common Stock Grants

  2,034,663   1,292,238   2,034,663   1,292,238 
                 

Total potentially dilutive shares

  18,564,732   17,822,307   18,564,732   17,822,307 

 

Variable Interest Entity. We determine whether an entity is a Variable Interest Entity ("VIE") and, if so, whether it should be consolidated by utilizing judgments and estimates that are inherently subjective. Our determination of whether an entity in which we hold a direct or indirect variable interest is a VIE is based on several factors, including whether we participated in the design of the entity and the entity’s total equity investment at risk upon inception is sufficient to finance the entity’s activities without additional subordinated financial support. We make judgments regarding the sufficiency of the equity at risk based first on a qualitative analysis, and then a quantitative analysis, if necessary.

 

We analyze any investments in VIEs to determine if we are the primary beneficiary. In evaluating whether we are the primary beneficiary, we evaluate our direct and indirect economic interests in the entity. A reporting entity is determined to be the primary beneficiary if it holds a controlling financial interest in the VIE. Determining which reporting entity, if any, has a controlling financial interest in a VIE is primarily a qualitative approach focused on identifying which reporting entity has both: (i) the power to direct the activities of a VIE that most significantly impact such entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits from such entity that could potentially be significant to such entity. Performance of that analysis requires the exercise of judgment.

 

We consider a variety of factors in identifying the entity that holds the power to direct matters that most significantly impact the VIE’s economic performance, including, but not limited to, the ability to direct operating decisions and activities. In addition, we consider the rights of other investors to participate in those decisions. We determine whether we are the primary beneficiary of a VIE at the time we become involved with a variable interest entity and reconsider that conclusion continually.  We consolidate any VIE of which we are the primary beneficiary.

 

The Company was involved in the formation of an entity considered to be a VIE, prior to September 22, 2023, when Murphy Canyon completed its business combination. The Company evaluated the consolidation of this entity as required pursuant to ASC Topic 810 relating to the consolidation of such VIE. The Company’s determination of whether it is the primary beneficiary of the VIE is based in part on an assessment of whether or not the Company and its related parties have the power to direct activities of the VIE and are exposed to the majority of the risks and rewards of the entity.  

 

15

 

Following the completion of the Murphy Canyon IPO in January 2022, we determined that Murphy Canyon was a VIE in which we had a variable interest because we participated in its formation and design, manage the significant activities, and Murphy Canyon did not have enough equity at risk to finance its activities without additional subordinated financial support. We have also determined that Murphy Canyon's public stockholders did not have substantive rights, and their equity interest constituted temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A. As such, we have concluded that, prior to the business combination, we were the primary beneficiary of Murphy Canyon as a VIE, as we had the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impacted Murphy Canyon's economic performance. Since we were the primary beneficiary, Murphy Canyon was consolidated into our consolidated financial statements. See Note 9 Investment in Conduit Pharmaceuticals for additional details regarding Murphy Canyon.

 

Shares Subject to Possible Redemption. Given that the shares of Murphy Canyon Class A common stock issued to investors in its IPO were issued with other freestanding instruments (i.e., public warrants which were classified as permanent equity as described below), the proceeds and initial carrying value of the Class A common stock classified as temporary equity was allocated in accordance with ASC 470-20. The Murphy Canyon Class A common stock was subject to ASC 480-10-S99. In addition, because it was probable that the equity instrument would become redeemable, we had the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it became probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occurred and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We elected to recognize the accretion resulting from changes in redemption value immediately during the three months ended March 31, 2022, and every quarter since then, until September 22, 2023 as noted above.  See Note 9 Investment in Conduit Pharmaceuticals for additional details regarding Murphy Canyon.

 

Immaterial Error Corrections. During the second quarter of 2024, management determined that its prior treatment of accruing restricted compensation expense as a liability and included in accounts payable and accrued liabilities on the consolidated balance sheets should be treated differently. Management determined that the restricted stock compensation should be treated as equity and included in additional paid in capital in the Company’s accompanying consolidated balance sheet for the prior years in accordance with ASC 718. Compensation - Stock Compensation. Accordingly, the Company’s accompanying consolidated balance sheets and consolidated statements of changes in equity as of December 31, 2022, and December 31, 2023, respectively, and for the three months ended March 31, 2023, June 30, 2023, and March 31, 2024, respectively, reflects an adjustment to include restricted stock compensation.

 

On the balance sheet as of December 31, 2023, accounts payable and accrued liabilities reflects a reduction of $21,189 and additional paid-in capital reflects an increases of $21,189.  On the consolidated statements of changes in equity, the three months ended March 31, 2023,  June 30, 2023 and September 30, 2023 reflect the addition of restricted stock compensation of $232,106, $228,657, and $270,564, respectively, and the three months ended March 31, 2024 includes restricted stock compensation of $317,077. The corrections did not affect Consolidated Statements of Operations or Consolidated Statements of Cash Flows in any prior periods.

 

During the third quarter of 2024, management determined that the consolidated statements of cash flows for the nine months ended September 30, 2023 and the year ended December 31, 2023, overstated the amount of cash outflows for building and tenant improvements as a portion of those additions were in accounts payable at the end of each period. For the nine months ended September 30, 2023 and the year ended December 31, 2023, $850,918 and $295,567, respectively, should have been disclosed as a supplemental disclosure of cash flow information as unpaid building and tenant improvements. These errors impact  the consolidated statement of cash flows and do not affect the consolidated balance sheets, consolidated statement of operations and consolidated statements of changes in equity. 

 

As such, the Company’s consolidated statement of cash flows for the nine months ended September 30, 2023, reflects an adjustment to reduce cash outflows for unpaid building and tenant improvements. For the nine months ended September 30, 2023, net cash provided by operating activities, as previously reported, of $488,137 was reduced by $850,918 and net cash provided by investing activities, as previously reported, of $128,168,785 was increased by $850,918.  Additionally, the $295,567 of unpaid building and tenant improvements that were recorded in accounts payable as of December 31, 2023, and paid in January 2024, are included in the statement of cash flows for the nine months ended September 30, 2024.

 

The effect of correcting the errors in operating and investing cash flows for unpaid building and tenant improvements for the three months ended March 31, 2024 was $48,207 and for the six months ended June 30, 2024 was $204,054, which will be reflected in the Company’s interim financial statements the next time these periods are presented.

 

Reclassifications. Certain prior year balance sheet, statement of operations and statement of cash flows accounts have been reclassified to conform with the current year presentation. The reclassifications did not affect net income in the prior year's consolidated statement of operations.

 

Subsequent Events. We evaluate subsequent events up until the date the consolidated financial statements are issued.

 

Recently Issued and Adopted Accounting Pronouncements.  In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes, to enhance income tax disclosures, provide more information about tax risks and opportunities present in worldwide operations, and to disaggregate existing income tax disclosures. The guidance is effective for annual periods beginning after December 15, 2024 on a prospective basis, with the option to apply the standard retrospectively. Early adoption is permitted. We have not yet adopted ASU 2023-09 and are currently evaluating the impact on our financial statement disclosures.


In November 2023, FASB issued Accounting Standards Update ASU 2023-07, Segment Reporting, establishing improvements to reportable segments disclosures to enhance segment reporting under Topic 280. This ASU aims to change how public entities identify and aggregate operating segments and apply quantitative thresholds to determine their reportable segments. This ASU also requires public entities that operate as a single reportable segment to provide all segment disclosures in Topic 280, not just entity level disclosures. The guidance will be effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024 and the amendments should be applied retrospectively to all periods presented in the financial statements. We have not yet adopted ASU 2023-07 and are currently evaluating the impact on our financial statement disclosures.

 

In August 2023, FASB issued Accounting Standards Update ("ASU") ASU 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805- 60): Recognition and Initial Measurement" ("ASU 2023-05"). ASU 2023-05 addresses the accounting for contributions made to a joint venture, upon formation, in a joint venture's separate financial statements. Prior to the amendment, the FASB did not provide specific authoritative guidance on the initial measurement of assets and liabilities assumed by a joint venture upon its formation. ASU 2023-05 requires a joint venture to recognize and initially measure its assets and liabilities at fair value (with exceptions to fair value measurement that are consistent with the business combinations guidance). ASU 2023-05 is effective for all joint venture formations with a formation date on or after January 1, 2025, with early adoption permitted. The Company has elected not to early adopt ASU 2023-05 and does not expect the adoption will have a significant impact on our consolidated financial statements.

 

In March 2024, the SEC issued final climate-disclosure rules to enhance and standardize climate‐related disclosures by public companies. With regards to financial statements, the rules requires disclosure of (i) capitalized costs, expenditures expensed, charges, and losses incurred as a result of severe weather events and other natural conditions, subject to applicable one percent and de minimis disclosure thresholds; (ii) capitalized costs, expenditures expensed, and losses related to carbon offsets and renewable energy credits or certificates (RECs) if used as a material component of a company's plans to achieve its disclosed climate-related targets or goals; and (iii) if the estimates and assumptions the company uses to produce the financial statements were materially impacted by risks and uncertainties associated with severe weather events and other natural conditions or any disclosed climate-related targets or transition plans, a qualitative description of how the development of such estimates and assumptions was impacted. The rules are effective for annual periods beginning January 1, 2025 and are to be applied prospectively. On April 4, 2024, the SEC voluntarily stayed the rules pending judicial review as a result of litigation.

 

In November 2024, FASB issued Accounting Standards Update ASU 2024-03, Income Statement—Reporting Comprehensive, Income—Expense Disaggregation Disclosures, Disaggregation of Income Statement Expenses (“ASU 2024-03”).  This ASU is to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, SG&A, and research and development).  The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. We have not yet adopted ASU 2024-03 and are currently evaluating the impact on our financial statement disclosures.

 

 

3. RECENT REAL ESTATE TRANSACTIONS

 

Acquisitions during the nine months ended September 30, 2024

 

 

The Company acquired 19 model homes for approximately $9.7 million. The purchase price was paid through cash payments of approximately $3.0 million and mortgage notes of approximately $6.7 million.

 

Acquisitions during the nine months ended September 30, 2023: 

 

 

The Company acquired 25 model homes for approximately $13.7 million. The purchase price was paid through cash payments of approximately $4.2 million and mortgage notes of approximately $9.5 million.

 

Dispositions during the nine months ended September 30, 2024:

 

 

The Company sold 46 model homes for approximately $22.3 million, net of sales costs, and recognized a gain of approximately $3.2 million.

 

Dispositions during the nine months ended September 30, 2023: 

 

 

The Company sold 15 model homes for approximately $7.8 million, net of sales costs, and recognized a gain of approximately $2.3 million.

 

16

 
 

4. REAL ESTATE ASSETS

 

The Company owns a diverse portfolio of real estate assets. The primary types of properties the Company invests in are office, industrial, retail, and triple-net leased model home properties.  We have five commercial properties located in Colorado, four in North Dakota, one in Southern California, one in Texas and one in Maryland. Our model home properties are located in three states. As of September 30, 2024, the Company owned or had an equity interest in:

 

 

Eight office buildings and one industrial property (“Office/Industrial Properties”) which total approximately 758,175 rentable square feet (unaudited);

   
 Three retail shopping centers (“Retail Properties”) which total approximately 65,242 rentable square feet (unaudited); and
   
 

83 model home residential properties (“Model Homes” or “Model Home Properties”), totaling approximately 251,602 square feet (unaudited), leased back on a triple-net basis to homebuilders, that are owned by five affiliated limited partnerships and one wholly-owned corporation, all of which we control.  As of  September 30, 2024, all of the model homes in Dubose Model Home Investors #206, LP had been sold.

 

A summary of the properties owned by the Company, including their lease intangibles, as of September 30, 2024 and  December 31, 2023 is as follows:

 

  

Date

   

Real estate assets and lease intangibles, net

 

Property Name

 

Acquired

 

Location

 

September 30, 2024

  

December 31, 2023

 

Genesis Plaza (1)

 

August 2010

 

San Diego, CA

 $7,216,589  $7,542,725 

Dakota Center (2)

 

May 2011

 

Fargo, ND

  8,268,657   9,201,883 

Grand Pacific Center (3)

 

March 2014

 

Bismarck, ND

  8,556,365   8,274,454 

Arapahoe Center

 

December 2014

 

Centennial, CO

  9,408,010   9,341,991 

Union Town Center (4)

 

December 2014

 

Colorado Springs, CO

  8,917,143   8,918,742 

West Fargo Industrial

 

August 2015

 

Fargo, ND

  6,626,155   6,819,765 

300 N.P.

 

August 2015

 

Fargo, ND

  2,711,700   2,774,176 

Research Parkway (4)

 

August 2015

 

Colorado Springs, CO

  2,220,283   2,266,173 

One Park Center (5)

 

August 2015

 

Westminster, CO

  5,651,067   5,700,000 

Shea Center II (6)

 

December 2015

 

Highlands Ranch, CO

  18,835,122   19,367,289 

Mandolin (7)

 August 2021 

Houston, TX

  4,623,490   4,692,274 

Baltimore

 

December 2021

 

Baltimore, MD

  8,297,634   8,466,165 

Commercial properties

       91,332,215   93,365,637 

Model Home properties (8)

 2017 - 2024 

AZ, FL, IL, TX, WI

  40,082,995   50,790,147 

Total real estate assets and lease intangibles, net

      $131,415,210  $144,155,784 

 

17

 

(1)

Genesis Plaza is owned by two tenants-in-common, NetREIT Genesis and NetREIT Genessis II, each of which own 57% and 43%, respectively, and we beneficially own an aggregate of 92.0%, based on our ownership of each entity.  We have 100% ownership of NetREIT Genesis and 81.5% ownership of NetREIT Genesis II, and we have control of both entities.  During July 2024 the Company completed a minority ownership conversion option as result of a death in a noncontrolling trust within NetREIT Genesis II.  The Company issued the trust 78,215 shares of SQFT Series A Common Stock in exchange for their 36.4% ownership in NetREIT Genesis II, as per the original exchange agreement.

 

(2)

The non-recourse loan on the Dakota Center property matured on July 6, 2024.  During October 2024, management has agreed with the lender to sell the property to settle the loan balance.  Due to the uncertainties in the Fargo market, we have impaired the property’s book value and recorded an impairment charge of approximately $0.7 million as of  September 30, 2024.

 

(3)

Grand Pacific Center, Bismarck, ND, was removed from held-for-sale after signing a major lease with KLJ Engineering on December 7, 2022 for approximately 33,296 usable square feet, a term of 122 months, and starting annualized rent of $532,736.  KLJ Engineering moved into the building during December 2023, with rent that commenced on February 28, 2024.

 

(4)

As of September 30, 2024, Union Town Center and Research Parkway have been listed for sale, and included in the real estate assets held for sale, net on the consolidated balance sheet as of September 30, 2024.  We expect a sale to take place during the fourth quarter of 2024, prior to the maturity of their loans.  If the sales take longer than expected, we have options available to extend the maturity of the loans to accommodate for a longer sales period.

 

(5)

During the year ended December 31, 2023, we recorded a $2.0 million impairment charge for One Park Center that reflects management’s revised estimate of the fair market value based on sales comparable of like properties in the same geographical area as well as an evaluation of future cash flows or an executed purchase sale agreement.  No additional impairment was deemed necessary during the nine months ended September 30, 2024

 

(6)

On December 31, 2022, the lease for our largest tenant, Halliburton, expired.  Halliburton was located in our Shea Center II property in Colorado, and made up approximately $536,080 of our annual base rent.  Halliburton did not renew the lease and we placed approximately $1.1 million in a reserve account with our lender to cover future mortgage payments, if necessary, none of which has been used as of December 31, 2023.  Our management team is working to fill the 45,535 square foot space and has leased approximately 35% of the space to a tenant during 2023 and 2024 and has reviewed various proposals for the remaining 65%. As of September 30, 2024, management is pursuing third party tenants who fit into our long-term plans, however, there is no guarantee we will be successful in signing new tenants.

 

(7)

A portion of the proceeds from the sale of Highland Court were used in like-kind exchange transactions pursued under Section 1031 of the Code for the acquisition of our Mandolin property. Mandolin is owned by NetREIT Palm Self-Storage LP, through its wholly owned subsidiary NetREIT Highland LLC, and the Company is the sole general partner and owns 61.3% of NetREIT Palm Self-Storage LP.

 

(8)

Includes Model Homes listed as held for sale as of September 30, 2024 and December 31, 2023.  During the three and nine months ended September 30, 2024, we recorded an impairment charge for model homes totaling $41,656 and $238,449, respectively, which reflects the estimated sales prices for these specific model homes after the closing of each quarter in 2024.  The short hold period, less than two years, and the builder changing their model style after we purchased the homes, contributed to the lower than expected sales price.

 

For the three and nine months ended September 30, 2024 depreciation expense totaled approximately $1.3 million and $3.8 million, respectively. For the three and nine months ended September 30, 2023 depreciation expense totaled approximately $1.2 million and $3.7 million, respectively.    

 

 

 
5. LEASE INTANGIBLES

 

The following table summarizes the net value of other intangible assets acquired and the accumulated amortization for each class of intangible asset:

 

  

September 30, 2024

  

December 31, 2023

 
  

Lease Intangibles

  

Accumulated Amortization

  

Lease Intangibles, net

  

Lease Intangibles

  

Accumulated Amortization

  

Lease Intangibles, net

 

In-place leases

 $2,515,264  $(2,502,353) $12,911  $2,515,264  $(2,495,016) $20,248 

Leasing costs

  1,261,390   (1,250,143)  11,247   1,261,390   (1,244,335)  17,055 

Above-market leases

           333,485   (333,485)   
  $3,776,654  $(3,752,496) $24,158  $4,110,139  $(4,072,836) $37,303 

 

18

   

At  September 30, 2024, and  December 31, 2023, there were no gross lease intangible assets and accumulated amortization related to the lease intangible assets included in real estate assets held for sale.

 

The net value of acquired intangible liabilities was approximately $9,535 and $13,266 relating to below-market leases at  September 30, 2024 and  December 31, 2023, respectively.

 

Future aggregate approximate amortization expense for the Company's lease intangible assets is as follows:

 

2024

 $4,382 

2025

  15,669 

2026

  4,107 

Total

 $24,158 

 

 

6. OTHER ASSETS

 

Other assets consist of the following:

 

  

September 30,

  

December 31,

 
  

2024

  

2023

 

Deferred rent receivable

 $2,087,378  $1,973,887 

Prepaid expenses, deposits and other

  636,704   349,160 

Notes receivable

  316,374   316,374 

Accounts receivable, net

  135,353   694,869 

Right-of-use assets, net

  69,962   15,649 

Deferred offering costs

     5,000 

Investment in marketable securities (not including Conduit)

     45,149 

Total other assets

 $3,245,771  $3,400,088 

 

Periodically, the Company may sell an option in the marketable securities it holds to unrelated third parties for the right to purchase certain securities held within its investment portfolios (“covered call options”). These option transactions are designed primarily to increase the total return associated with holding the related securities as earning assets by using fee income generated from these options. These transactions are not designated as hedging relationships pursuant to accounting guidance ASC 815 and, accordingly, changes in fair values of these contracts, are reported in other income (expense).  There are several risks associated with transactions in options on securities. For example, there are significant differences between the securities and options markets that could result in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A transaction in options or securities may be unsuccessful to some degree because of market behavior or unexpected events. When we write a covered call option, we forgo, during the option’s life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium and the strike price of the call but retain the risk of loss should the price of the underlying security decline. The writer of an option has no control over the time when it may be required to fulfill its obligation before the sold option expires, and once an option writer has received an exercise notice, it must deliver the underlying security in exchange for the strike price.
 

As of September 30, 2024, we did not own common shares of other publicly traded REITs.  As of December 31, 2023, we owned common shares of 3 different publicly traded REITs and covered call options in zero of those same REITs.  The gross fair market value on our publicly traded REIT securities was $45,149, with covered call options totaling $0.  As of December 31, 2023, the net fair value of our publicly traded REIT securities was $45,149 based on the December 31, 2023 closing prices. 

 

19

 
 

7. MORTGAGE NOTES PAYABLE

 

Mortgage notes payable consist of the following:

 

  

Principal as of

          
  

September 30,

  

December 31,

 

Loan

 

Interest

     

Mortgage note property

 

2024

  

2023

 

Type

 

Rate (1)

  

Maturity

 

Dakota Center (2)

 $9,091,395  $9,197,346 

Fixed

  4.74% 

7/6/2024

 

Research Parkway (6)

  1,542,559   1,588,742 

Fixed

  3.94% 

1/5/2025

 

Arapahoe Service Center (6)

  7,289,903   7,426,088 

Fixed

  4.34% 

1/5/2025

 

Union Town Center (6)

  7,751,042   7,870,468 

Fixed

  4.28% 

1/5/2025

 

One Park Centre (6)

  5,951,566   6,043,882 

Fixed

  4.77% 

9/5/2025

 

Genesis Plaza (6)

  5,845,630   5,937,251 

Fixed

  4.71% 

9/6/2025

 

Shea Center II

  16,735,875   16,951,095 

Fixed

  4.92% 

1/5/2026

 

West Fargo Industrial (3)

  5,750,000   3,922,829 

Fixed

  7.14% 

7/6/2029

 

Grand Pacific Center (4)

  6,477,723   5,470,305 

Fixed

  6.35% 

5/5/2033

 

Baltimore

  5,670,000   5,670,000 

Fixed

  4.67% 

4/6/2032

 

Mandolin

  3,525,307   3,573,201 

Fixed

  4.35% 4/20/2029 

Subtotal, Presidio Property Trust, Inc. Properties

 $75,631,000  $73,651,207          

Model Home mortgage notes (5)

  27,537,755   34,815,699 

Fixed

      2024 - 2029 

Mortgage Notes Payable

 $103,168,755  $108,466,906          

Unamortized loan costs

  (849,536)  (753,633)         

Mortgage Notes Payable, net

 $102,319,219  $107,713,273          

 

(1)

Interest rates as of September 30, 2024.

(2)

The non-recourse loan on the Dakota Center property matured on  July 6, 2024.  Management has been in negotiations with the special servicer of the loan in modifying and/or extending the loan or possibly selling the building. We have not been able to come to an agreement regarding a situation in which the loan is modified or extended.  As such, in October 2024 we have offered the property for sale in conjunction with the lender’s approval  in attempts to make the lender whole, although there is no guarantee we will be able to do so.  The loan is considered non-recourse and we will not be required to make up the difference if the property sells for less than the loan balance.  See Note 4. Real Estate Assets above for further discussion on impairment of the property.

(3)

On June 20, 2024, the Company, through its subsidiary, refinanced the mortgage loan on our West Fargo Industrial properties, and entered into a loan agreement for approximately $5.75 million, a term of five years, with an interest rate of 7.14%.  The loan agreement has a Debt Service Coverage Ratio ("DSCR") minimum of 1.20 to 1.00 as calculated by Lender, in which: (a) the numerator is the Underwritten Net Cash Flow, and (b) the denominator is the annual Debt Service, tested at the end of each fiscal quarter.

(4)

On May 5, 2023, the Company, through its subsidiary, refinanced the mortgage loan on our Grand Pacific Center property and entered into a construction loan related to the tenant improvement associated with the KLJ Engineering LLC lease to occupy 33,296 square feet of the building. The refinanced loan is for approximately $3.8 million, a term of 10 years, with an interest rate of 6.35%, for the first 60 months.  The interest rate is subject to reset in year five on June 10, 2028. The construction loan is for approximately $2.7 million, a term of 10 years, and will begin amortizing in year three, with an interest rate of 6.35%, for the first 60 months. The interest rate is subject to reset in year five on June 10, 2028.  As of September 30, 2024, we had fully drawn down the loan amount of approximately $2.7 million on the construction loan.

(5)

As of September 30, 2024, there were 5 model homes included as real estate assets held for sale.  Our model homes have stand-alone mortgage notes at interest rates ranging from 4.51% to 8.0% per annum as of  September 30, 2024.

(6)

These mortgage loans mature within the next twelve months and management is reviewing various options for the loan maturity, including but not limited to refinancing, restructuring and or selling these properties.  As we get closer to the loan maturity date, the Company will finalize our plans.  Union Town Center and Research Parkway have been listed for sale, and included in the real estate assets held for sale, net on the consolidated balance sheet as of September 30, 2024.  We expect a sale to take place during the fourth quarter of 2024, prior to the maturity of the loans for Union Town Center and Research Parkway.  If the sales take longer than expected, we have options available to extend the maturity of the loan to accommodate for a longer sales period.  As of  September 30, 2024, we were reviewing terms sheets to refinance the loan on Arapahoe Service Center from third party lenders.

 

The loan agreement between NetREIT Model, Homes, Inc. (“NRMH”) and its Lender has a covenant for a Fixed Charge Coverage Ratio (“FCCR”) as defined for NRMH as of any date that equals (a) the sum of (i) EBITDA for the period ended as of such date minus (ii) distributions for the period ended as of such date divided by (b) the sum of (i) principal payments paid for the period ended as of such date plus (ii) interest expense for period ended as of such date.  The FCCR is to be no less than 1.10 to 1.00, tested at the end of each fiscal quarter.  As of December 31, 2023, NRMH was in compliance with this covenant.  The Company and standalone subsidiaries have other various quarterly and annual reporting requirements to the individual property lenders and the Company is in compliance with all material conditions and covenants on those mortgage notes payable as of September 30, 2024, with the exception for Dakota Center's loan maturity. 

 

20

 

Scheduled principal payments of mortgage notes payable were as follows as of September 30, 2024:

 

  

Commercial

  

Model

     
  

Properties

  

Homes

  

Total Principal

 

Years ending December 31:

 Notes Payable  Notes Payable  Payments 

2024

 $9,367,570  $2,321,811  $11,689,381 

2025

  28,644,941   8,885,311   37,530,252 

2026

  16,521,100   1,008,650   17,529,750 

2027

  157,739   551,267   709,006 

2028

  168,907   9,119,969   9,288,876 

Thereafter

  20,770,743   5,650,747   26,421,490 

Total

 $75,631,000  $27,537,755  $103,168,755 

 

 

8. NOTES PAYABLE

 

On April 22, 2020, the Company received an Economic Injury Disaster Loan of $10,000 from the Small Business Administration ("SBA") to provide economic relief during the COVID-19 pandemic. This loan advance is not required to be repaid, has no stipulations on use, and has been recorded as fees and other income in the consolidated statements of operations during fiscal 2020. On August 17, 2020, we received an additional Economic Injury Disaster Loan ("EIDL") of $150,000, for which principal and interest payments are deferred for twelve months from the date of issuance, and interest accrues at 3.75% per year. The loan matures on August 17, 2050. We have used the funds for general corporate purposes to alleviate economic damage caused by the COVID-19 pandemic, which economic injury included abating or deferring rent to certain tenants (primarily retail tenants).  As of  September 30, 2024, the balance of this loan totaled approximately $144,854 and is included in accounts payable and accrued liabilities on the consolidated balance sheet.

 

As of September 30, 2024, we had issued one promissory note to our majority owned subsidiary, Dubose Model Home Investors 202 LP, for the refinancing of one model home property in Texas, for approximately $0.3 million with an interest rate of 5.55% per annum and original maturity date of August 15, 2024, which was extended for another year with an interest rate of 8.0% per annum. This note payable and note receivable, including interest expense and interest income related to this promissory note, is eliminated through consolidation on our financial statements.  This property was subsequently sold in October 2024, and the loan was paid in full.

 

9. INVESTMENT IN CONDUIT PHARMACEUTICALS

 

Sponsorship of Special Purpose Acquisition Company. On January 7, 2022, we announced our sponsorship, through our wholly-owned subsidiary, Murphy Canyon Acquisition Sponsor, LLC (the "Sponsor"), of a special purpose acquisition company ("SPAC") initial public offering. The SPAC raised $132,250,000 in capital investment to acquire one or more businesses. We, through our wholly-owned subsidiary, owned approximately 23.5% of the issued and outstanding stock in the entity upon the initial public offering being declared effective and consummated (excluding the private placement units described below). The SPAC offered 132,250,000 units, with each unit consisting of one share of common stock and three-quarters of one redeemable warrant. The warrants were evaluated using the guidance in ASC 480 "Distinguishing Liabilities from Equity" and we concluded that the warrants are indexed to Murphy Canyon's common stock and meet the criteria to be classified in stockholders' equity.

 

The Murphy Canyon IPO of 13,225,000 units of common stock and warrants, closed on February 7, 2022, raising gross proceeds for Murphy Canyon of $132,250,000, including the exercise in full by the underwriters of their over-allotment option. In connection with the IPO, we purchased, through the Sponsor, 754,000 placement units (the "placement units") at a price of $10.00 per unit, for an aggregate purchase price of $7,540,000. These proceeds were deposited in a trust account established for the benefit of the Murphy Canyon public shareholders and are included in Investments held in Trust.In connection with the initial public offering, Murphy Canyon incurred $7,738,161 in issuance costs, including $2,645,000 of underwriting discounts and commission, $4,628,750 of deferred underwriting fees and $464,411 of other offering costs. These costs were allocated to temporary and permanent equity and offset against the proceeds.

 

On November 8, 2022, the SPAC entered into an agreement and plan of merger with Conduit Pharmaceuticals Limited, a Cayman Islands exempted company ("Conduit Pharma"), and Conduit Merger Sub, Inc., a Cayman Islands exempted company and the SPAC's wholly owned subsidiary. The merger agreement provided that the SPAC's Cayman Island subsidiary will merge with and into Conduit Pharma, with Conduit Pharma surviving the merger as the SPAC's wholly owned subsidiary and the public company renamed "Conduit Pharmaceuticals Inc." ("Conduit").

 

21

 
Initially, the SPAC was required to complete its initial business combination transaction by 12 months from the consummation of its initial public offering or up to 18 months if it extended the period of time to consummate a business combination in accordance with its Certificate of Incorporation. On January 26, 2023, at a special meeting of the stockholders, the stockholders approved a proposal to amend the SPAC's certificate of incorporation to extend the date by which it has to consummate a business combination up to 12 times, each such extension for an additional one-month period, from February 7, 2023 to February 7, 2024. The stockholders also approved a related proposal to amend the trust agreement allowing the SPAC to deposit into the trust account, for each one-month extension, one- third of 1% of the funds remaining in the trust account following the redemptions made in connection with the approval of the extension proposal at the special meeting. The Company has committed to providing additional funds if needed to make such a deposit for the extension. In connection with the stockholders' vote at the special meeting, 11,037,272 shares of common stock were tendered for redemption, which were redeemed in February 2023. Approximately $114.1 million in cash was removed from the Trust Account to pay such stockholders and, accordingly, after giving effect to such redemptions, income tax withdraws of $200,050 and adding $155,403 in extension payments, the balance in the Trust Account was approximately $23.3 million. After the redemptions, there were 2,187,728 shares of SPAC Class A common stock subject to possible redemption.

 

On January 27, 2023, the merger agreement was amended to provide for only one class of authorized common stock of the SPAC following the business combination, instead of both authorized Class A common stock and Class B common stock as set forth in the original merger agreement. On May 11, 2023, the merger agreement was further amended to provide for (i) removal of the provision that indicates that no tax opinion would be delivered in connection with the closing, (ii) a closing obligation that that the SPAC either (a) be exempt from the provisions of Rule 419 promulgated under the Securities Act of 1933, as amended, other than through its net tangible assets or (b) have at least $5,000,001 of net tangible assets either immediately prior to or upon consummation of the merger, and (iii) extension of the outside date for the closing of the merger from May 31, 2023 to February 7, 2024.

 

The investments held in Trust for the SPAC Class A common stockholders generated approximately $1.2 million of income during the nine months ended September 30, 2023, and was included in interest and other income (expense), net on our consolidated statement of operations.  As of September 22, 2023, the Trust account balance had been deconsolidated along with the other Conduit assets and liabilities.

 

As of immediately prior to the consummation of the SPAC's business combination, which occurred on September 22, 2023, the Company, through its subsidiary, had loaned the SPAC $1.0 million to fund its trust account and for operating expenses. The loan was non-interest bearing, unsecured and was repaid in full upon the SPAC's business combination on September 22, 2023. The notes payable and notes receivable related to the SPAC were eliminated through consolidation on our financial statements.

 

On September 22, 2023, the SPAC completed its business combination with Conduit Pharma and changed its name to Conduit Pharmaceuticals Inc. ("Conduit"). Immediately prior to the business combination, the Company owned approximately 65% of the SPAC's outstanding common stock. Upon consummation of the business combination, the SPAC's shares of Class B common stock were converted into shares of its Class A common stock and the shares of Class A common stock were then reclassified as a single class of Conduit common stock. As a result of the business combination, the Company was issued (i) 3,306,250 shares of Conduit's common stock due to the conversion of the shares of the SPAC's Class B common stock into shares of the SPAC's Class A common stock and then reclassification into shares of Conduit common stock, (ii) 754,000 shares of Conduit common stock, which prior to the business combination were shares of the SPAC's Class A common stock and (iii) private warrants to purchase 754,000 shares of Conduit common stock, which prior to the business combination were warrants to purchase 754,000 shares of the SPAC's Class A common stock. Also in the business combination, shareholders and debtholders of Conduit Pharma were issued 65,000,000 shares of Conduit common stock. Immediately following the consummation of the business combination, the Company transferred 45,000 shares of Conduit common stock and warrants to purchase 45,000 shares of Conduit common stock to the SPAC's independent directors as compensation for their services. As a result, the Company owned approximately 6.5% of Conduit's common stock immediately following the business combination, assuming all warrants owned by the Company were exercised and as of September 30, 2024, we own approximately 5.4% of Conduit's common stock, assuming all warrants owned by the Company are exercised. In connection with the business combination, the Company's officers and directors who also served as officers and directors of the SPAC resigned from the SPAC, with the exception of the Company's former Chief Financial Officer who resigned from the Company.

 

Following the completion of the Murphy Canyon IPO in February 2022, we determined that Murphy Canyon is a Variable Interest Entity ("VIE") in which we had a variable interest because Murphy Canyon did not have enough equity at risk to finance its activities without additional subordinated financial support. Since the business combinations with Conduit on September 22, 2023, we have determined that Conduit's (formally Murphy Canyon) public stockholders have substantive rights and we no longer have control of Conduit's activity. Since we are no longer the controlling party, or have a majority of the issued and outstating common stock, the Company deconsolidated Conduit from our consolidated financial statements. In connection with the deconsolidation we recorded a gain of approximately $40.3 million. Of the total gain recognized on deconsolidation, approximately $34.1 million relates to the remeasurement of our retained investment in Murphy Canyon via the Sponsor shares which converted into shares of Conduit's common stock on September 22, 2023, and approximately $6.2 million relates to the deconsolidation of Murphy Canyon's assets and liabilities as of September 22, 2023.

 

22

 

Since deconsolidating Conduit, on September 22, 2023, our investments in Conduit's common stock (CDT) and public common stock warrants (CDTTW) and Private CDT Warrants presented on the consolidated balance sheets were measured at fair value using Level 1 and Level 3 market prices, taking into account the adoption of ASU 2022-03 Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, and totaled approximately $0.5 million as of September 30, 2024, with a cost basis of approximately $7.5 million. The Company entered into a lock-up agreement with Conduit regarding certain of the common stock held by the Company, for 180 days from the closing of the business combination which ended March 20, 2024.

 

On April 22, 2024, the Company entered into a lockup agreement with Conduit pursuant to which the Company agreed not to transfer or sell 2,700,000 of its 4,015,250 shares of Conduit common stock for a period of one year.  In consideration for entering into the lockup agreement, Conduit issued the Company a warrant to purchase 540,000 shares of common stock at an exercise price of $3.12 per share, with a two year term and exercisable one year after the date of issue.  On September 30, 2024, our investments in Conduit's common stock ("CDT") and common stock warrants ("CDTTW") presented on the consolidated balance sheets were measured at fair value using Level 1 market prices, which closed at $0.1185 per share and $0.0118 per warrant.  The Private CDT Warrants were measured at fair value using Level 3 pricing with no value per warrant.

 

10. COMMITMENTS AND CONTINGENCIES

 

The Company is obligated under certain tenant leases to fund tenant improvements and the expansion of the underlying leased properties. As of September 30, 2024 , approximately $1.0  million is estimated for such capital expenditures on existing properties, net of any construction financing, during the rest of the year.
 
Activist stockholder activities could adversely affect our business because responding to proxy contests and reacting to other actions by activist stockholders can be costly and time-consuming, disrupt our operations and divert the attention of management and our employees. We have or in the future may retain the services of various professionals to advise us on activist stockholder matters, including legal, financial, strategic and communication advisors, the costs of which may negatively impact our future financial results. In addition, perceived uncertainties as to our future direction, strategy or leadership created as a consequence of activist stockholders' initiatives may result in the loss of potential business opportunities, harm our ability to attract new investors, business partners, and employees, and cause our stock price to experience periods of volatility or stagnation. On March 13, 2024, a stockholder activist group announced its intention to file a preliminary proxy statement and accompanying WHITE universal proxy card with the Securities and Exchange Commission to be used to solicit votes for the election of director nominees at our next annual meeting of stockholders. On May 9, 2024, the Company entered into a cooperation agreement with this stockholder group pursuant to which Elena Piliptchak was appointed to our board of directors, effective immediately, as a Class III director with a term expiring at Presidio's 2026 Annual Meeting of Stockholders. In connection with this appointment, our board of directors has been increased from six to seven directors. Pursuant to the agreement, the stockholder group agreed to withdraw the director nominations it had previously submitted and  support our board's slate of directors at the 2024 Annual Meeting of Stockholders, which was held on June 27, 2024. The stockholder group has also agreed to certain customary standstill provisions and voting commitments. We have evaluated this contingency and have determined a material loss is not probable or estimable at this time.
 
Litigation. From time to time, we may become involved in various lawsuits or legal proceedings which arise in the ordinary course of business. Neither the Company nor any of the Company's properties are presently subject to any material litigation nor, to the Company's knowledge, is there any material threatened litigation.
 

Environmental matters. The Company monitors its properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist, the Company is not currently aware of any environmental liability with respect to the properties that would have a material effect on the Company's financial condition, results of operations and cash flow. Further, the Company is not aware of any environmental liability or any unasserted claim or assessment with respect to an environmental liability that the Company believes would require additional disclosure or recording of a loss contingency.

 

Financial Markets. The Company monitors concerns over economic recession, interest rate increases, policy priorities of the U.S. presidential administration, trade wars, labor shortages, and inflation, any of which  may contribute to increased volatility and diminished expectations for the economy and markets. Additionally, the economic and geopolitical ramifications of the military conflicts in the Middle East and Ukraine, including sanctions, retaliatory sanctions, nationalism, supply chain disruptions and other consequences,   could impact commercial real estate fundamentals and result in lower occupancy, lower rental rates, and declining values in our real estate portfolio and in the collateral securing our loan investments. We have not currently experienced a direct material impact to our Company or operations; however, we will continue to monitor the financial markets for events that could impact our commercial real estate properties.

 

23

 
 

11. STOCKHOLDERS' EQUITY

 

Preferred Stock. The Company is authorized to issue up to 1,000,000 shares of Preferred Stock (the "Preferred Stock"). The Preferred Stock may be issued from time to time in one or more series. The Board of Directors is authorized to fix the number of shares of any series of the Preferred Stock, to determine the designation of any such series, and to set the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications and terms or conditions of redemption for each series of Preferred Stock. 

 

On June 15, 2021, the Company completed its secondary offering of 800,000 shares of our Series D Preferred Stock for cash consideration of $25.00 per share to a syndicate of underwriters led by The Benchmark Company, LLC, as representative, resulting in approximately $18.1 million in net proceeds, after deducting the underwriting discounts and commissions and the offering expenses paid by the Company. The Company granted the underwriters a 45-day option to purchase up to an additional 120,000 shares of Series D Preferred Stock to cover over-allotments, which they exercised on June 17, 2021, resulting in approximately $2.7 million in net proceeds, after deducting the underwriting discounts and commissions and the offering expenses paid by the Company.  In total, the Company issued 920,000 shares of Series D Preferred Stock with net proceeds of approximately $20.5 million, after deducting the underwriting discounts and commissions and the offering expenses paid by the Company and deferred offering costs.  The Series D Preferred Stock is listed for trading on The Nasdaq Capital Market under the symbol SQFTP.   The Company has used these proceeds for general corporate and working capital purposes, including acquiring additional properties. 

 

On June 20, 2024, the  Company entered into an underwriting agreement with The Benchmark Company, LLC  pursuant to which the Company issued and sold in an underwritten public offering 109,054 shares of the Company’s Series D Preferred Stock. The shares of Series D Preferred Stock were sold to the public at a price of $16.00 per share. The Company agreed to an underwriting discount of 7% of the public offering price of the shares of Series D Preferred Stock sold in the offering. The offering closed on June 24, 2024, generating gross proceeds of approximately $1.74 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for general corporate and working capital purposes, including to potentially acquire additional properties. Below are some of the key terms of the Series D Preferred Stock:

 

Dividends:

Holders of shares of the Series D Preferred Stock are entitled to receive cumulative cash dividends at a rate of 9.375% per annum of the $25.00 per share liquidation preference (equivalent to $2.34375 per annum per share). Dividends will be payable monthly on the 15th day of each month (each, a "Dividend Payment Date"), provided that if any Dividend Payment Date is not a business day, then the dividend that would otherwise have been payable on that Dividend Payment Date may be paid on the next succeeding business day without adjustment in the amount of the dividend.

 

Voting Rights:

Holders of shares of the Series D Preferred Stock will generally have no voting rights. However, if the Company does not pay dividends on the Series D Preferred Stock for eighteen or more monthly dividend periods (whether or not consecutive), the holders of the Series D Preferred Stock (voting separately as a class with the holders of all other classes or series of the Company's preferred stock it may issue upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Series D Preferred Stock in the election referred to below) will be entitled to vote for the election of two additional directors to serve on the Company's Board of Directors until the Company pays, or declares and sets apart funds for the payment of, all dividends that it owes on the Series D Preferred Stock, subject to certain limitations.

 

In addition, the affirmative vote of the holders of at least two-thirds of the outstanding shares of Series D Preferred Stock (voting together as a class with all other series of parity preferred stock the Company may issue upon which like voting rights have been conferred and are exercisable) is required at any time for the Company to (i) authorize or issue any class or series of its stock ranking senior to the Series D Preferred Stock with respect to the payment of dividends or the distribution of assets on liquidation, dissolution or winding up or (ii) to amend any provision of the Company charter so as to materially and adversely affect any rights of the Series D Preferred Stock or to take certain other actions. 

 

Liquidation Preference:

In the event of the Company's voluntary or involuntary liquidation, dissolution or winding up, the holders of shares of Series D Preferred Stock will be entitled to be paid out of the assets the Company has legally available for distribution to its stockholders, subject to the preferential rights of the holders of any class or series of its stock the Company may issue ranking senior to the Series D Preferred Stock with respect to the distribution of assets upon liquidation, dissolution or winding up, a liquidation preference of $25.00 per share, plus any accumulated and unpaid dividends to, but not including, the date of payment, before any distribution of assets is made to holders of the Company's common stock or any other class or series of the Company's stock it may issue that ranks junior to the Series D Preferred Stock as to liquidation rights.

 

24

 

In the event that, upon any such voluntary or involuntary liquidation, dissolution or winding up, the Company's available assets are insufficient to pay the amount of the liquidating distributions on all outstanding shares of Series D Preferred Stock and the corresponding amounts payable on all shares of other classes or series of the Company's stock that it issues ranking on parity with the Series D Preferred Stock in the distribution of assets, then the holders of the Series D Preferred Stock and all other such classes or series of stock shall share ratably in any such distribution of assets in proportion to the full liquidating distributions to which they would otherwise be respectively entitled.

   

Redemption:

Commencing on or after June 15, 2026, the Company may redeem, at its option, the Series D Preferred Stock, in whole or in part, at a cash redemption price equal to $25.00 per share, plus any accumulated and unpaid dividends to, but not including the redemption date. Prior to June 15, 2026, upon a Change of Control (as defined in the Articles Supplementary), the Company may redeem, at its option, the Series D Preferred Stock, in whole or part, at a cash redemption price of $25.00 per share, plus any accumulated and unpaid dividends to, but not including the redemption date. The Series D Preferred Stock has no stated maturity, will not be subject to any sinking fund or other mandatory redemption, and will not be convertible into or exchangeable for any of our other securities. 

 

In accordance with the terms of the Series D Preferred Stock, the Series D monthly dividend has been approved by the Board of Directors through September 30, 2024 in the amount of $0.19531 per share payable on the 15th of every month to stockholders of record of Series D Preferred Stock as of the last day of the prior month.  Total dividends paid to Series D Preferred stockholders during the three and nine months ended September 30, 2024 were approximately $0.6 million and $1.7 million, respectively.  Total dividends paid to Series D Preferred stockholders during the three and nine months ended September 30, 2023 were approximately $0.5 million and $1.6 million, respectively.

 

Common Stock. The Company is authorized to issue up to 100,000,000 shares of Series A Common Stock, 1,000 shares of Series B Common Stock, and 9,000,000 shares of Series C Common Stock (collectively, the "Common Stock") each with $0.01 par value per share. Each class of Common Stock has identical rights, preferences, terms, and conditions except that the holders of Series B Common Stock are not entitled to receive any portion of Company assets in the event of the Company's liquidation. No shares of Series B or Series C Common Stock have been issued. Each share of Common Stock entitles the holder to one vote. Shares of our Common Stock are not subject to redemption and do not have any preference, conversion, exchange, or preemptive rights. The Company's charter contains restrictions on the ownership and transfer of the Common Stock that prevents one person from owning more than 9.8% of the outstanding shares of common stock.  The Board of Directors granted our CEO, Jack Heilbron, and CIO, Gary Katz, an exception to the 9.8% ownership limit and established an excepted holder limit permitting each of Jack Heilbron and Gary Katz to beneficially or constructively own up to 19% of the outstanding shares of our common stock, including warrants, subject to compliance with Article VII of the Company’s charter.

 

On July 12, 2021, the Company entered into a securities purchase agreement with a single U.S. institutional investor for the purchase and sale of 1,000,000 shares of its Series A Common Stock, Common Stock Warrants to purchase up to 2,000,000 shares of Series A Common Stock and Pre-Funded Warrants to purchase up to 1,000,000 shares of Series A Common Stock. Each share of Common Stock and accompanying Common Stock Warrants were sold together at a combined offering price of $5.00, and each share of Common Stock and accompanying Pre-Funded Warrants were sold together at a combined offering price of $4.99. The Pre-Funded Warrants were exercised in full during August 2021 at a nominal exercise price of $0.01 per share. The Common Stock Warrants have an exercise price of $5.50 per share, were exercisable upon issuance and will expire five years from the date of issuance. 

 

In connection with this additional offering, we agreed to issue the Placement Agent Warrants to purchase up to 80,000 shares of Series A Common Stock, representing 4.0% of the Series A Common Stock and shares of Series A Common Stock issuable upon exercise of the Pre-Funded Warrant.  The Placement Agent Warrants were issued in August 2021, post exercise of the Pre-Funded Warrants with an exercise price of $6.25 and will expire five years from the date of issuance. The Company evaluated the accounting guidance in ASC 480 and ASC 815 regarding the classification of the Pre-Funded Warrant, Common Stock Warrants, and Placement Agent Warrants as equity or a liability and ultimately determined that it should be classified as permanent equity.  As of September 30, 2024, none of the Common Stock Warrants and Placement Agent Warrants have been exercised.

 

Genesis Plaza is owned by two tenants-in-common, NetREIT Genesis and NetREIT Genessis II, each of which own 57% and 43%, respectively, and we beneficially own an aggregate of 92.0%, based on our ownership of each entity.  We have 100% ownership of NetREIT Genesis and 81.5% ownership of NetREIT Genesis II, and we have control of both entities.  During July, 2024 the Company completed a minority ownership conversion option as result of a death in a noncontrolling trust within NetREIT Genesis II.  The Company issued the trust 78,215 shares of SQFT Series A Common Stock in exchange for their 36.4% ownership in NetREIT Genesis II, as per the original exchange agreement at $9.30 per share.

 

25

 

Stock Repurchase Program. While we will continue to pursue value creating investments, the Board of Directors believes there is significant embedded value in our assets that is yet to be realized by the market. Therefore, returning capital to stockholders through a repurchase program is an attractive use of capital currently. On September 15, 2022, the Board of Directors authorized a stock repurchase program of up to $6.0 million of outstanding shares of our Series A Common Stock and up to $4.0 million of our Series D Preferred Stock, which expired in September 2023. In November 2023, the Board of Directors authorized a stock repurchase program of up to $6.0 million of outstanding shares of our Series A Common Stock and up to $4.0 million of our Series D Preferred Stock which shall expire in November 2024. During the year ended December 31, 2023, the Company repurchased 23,041 shares of our Series D Preferred Stock at an average price of approximately $16.06 per share, including a commission of $0.035 per share, and no shares of our Series A Common Stock, for a total cost of $0.4 million for the Series D Preferred Stock. During the nine months ended September 30, 2024, we repurchased 137,709 shares of our Series A Common Stock, for a total cost of $97,394, with an average price of approximately $0.7072 per share. There were no repurchases of Series D Preferred Stock during the nine months ended September 30, 2024. Any repurchased shares are treated as authorized and unissued in accordance with Maryland law and shown as a reduction of stockholders’ equity at cost.

 

Cash Dividends on Common Stock and Preferred Stock. For the three and nine months ended September 30, 2024, the Company has not declared a cash dividend on shares of Series A Common Stock. For the three and nine months ended September 30, 2023, the Company declared and paid approximately $0.3 million and $0.9 million, respectively, in cash dividends on shares of Series A Common Stock. For the three and nine months ended September 30, 2024, the Company declared and paid approximately $0.6 million and $1.7 million, respectively, in cash dividends on shares of Series D Preferred Stock. For the three and nine months ended September 30, 2023, the Company declared and paid approximately $0.5 million and $1.6 million, respectively, in cash dividends on shares of Series D Preferred Stock. Cash permitting, the Company intends to continue to pay dividends to our common stockholders on a quarterly basis and on a monthly basis to holders of our Series D Preferred Stock going forward, but there can be no guarantee the Board of Directors will approve any future dividends. The Company is still considering how much it may pay during the next quarter, as there was no cash dividend paid during the first three quarters of 2024 on shares of Series A Common Stock.  The following is a summary of distributions declared per share of our Series A Common Stock and for our Series D Preferred Stock for the nine months ended September 30, 2024 and 2023.

 

Series A Common Stock

 

Quarter Ended

 

2024

  

2023

 
  

Distributions Declared

  

Distributions Declared

 

March 31

 $-  $0.022 

June 30

  -   0.023 

September 30

  -   0.023 

Total

 $-  $0.045 

 

Series D Preferred Stock

 

Month

 

2024

  

2023

 
  

Distributions Declared

  

Distributions Declared

 

January

 $0.19531  $0.19531 

February

  0.19531   0.19531 

March

  0.19531   0.19531 

April

  0.19531   0.19531 

May

  0.19531   0.19531 

June

  0.19531   0.19531 

July

  0.19531   0.19531 

August

  0.19531   0.19531 

September

  0.19531   0.19531 

Total

 $1.75779  $1.75779 

 

Partnership Interests. Through the Company, its subsidiaries, and its partnerships, we own 12 commercial properties in fee interest, two of which we own partial interests in through our holdings in various affiliates in which we serve as general partner, member and/or manager. Each of the limited partnerships is referred to as a "DownREIT." In each DownREIT, we have the right, through put and call options, to require our co-investors to exchange their interests for shares of our Common Stock at a stated price after a defined period (generally five years from the date they first invested in the entity's real property), the occurrence of a specified event or a combination thereof. The Company is a limited partner in five partnerships and sole stockholder in one corporation, which entities purchase and leaseback model homes from homebuilders.

 

26

 
 

12. SHARE-BASED INCENTIVE PLAN

 

The Company maintains a restricted stock incentive plan for the purpose of attracting and retaining officers, employees, and non-employee board members. Share awards generally vest in equal annual installments over a three-to-ten-year period from date of issuance. Non-vested shares have voting rights and are eligible for any dividends paid on shares of common stock. The Company recognized compensation cost for these fixed awards over the service vesting period, which represents the requisite service period, using the straight-line method. Prior to our IPO, the value of non-vested shares was calculated based on the offering price of the shares in the most recent private placement offering of $20.00, adjusted for stock dividends since granted and assumed selling costs, which management believed approximated fair market value as of the date of grant. Upon our IPO, the value of non-vested shares granted is generally calculated based on the closing price of our common stock on the date of the grant.

 

During our Annual Stockholders meeting, held on May 26, 2022, the Company's 2017 Incentive Award Plan was amended to increase the available shares for issuance from 1.1 million to 2.5 million and at our Annual Stockholders meeting, held on June 1, 2023, the Company's 2017 Incentive Award Plan was amended to increase the available shares for issuance from 2.5 million to 3.5 million and add an evergreen provision to, on April 1st and October 1st of each year, automatically increase the maximum number of shares of common stock available under the plan to 15% of the Company's outstanding shares of common stock, if on such date 3,500,000 (as adjusted for any reverse splits) is less than 15% of the Company's then-outstanding shares of common stock.

 

A summary of the activity for the Company's restricted stock was as follows:

 

Outstanding shares:

 

Common Shares

 
     

Balance at December 31, 2023

  760,995 

Granted

  1,437,746 

Vested

  (164,078)

Balance at September 30, 2024

  2,034,663 

 

The non-vested restricted shares outstanding as of September 30, 2024, will vest over the next one to four years.  As of  September 30, 2024, there were approximately 63,000 shares available to grant under the Company's 2017 Incentive Award Plan.  Included in the Granted and Vested totals noted above are 149,253 shares of common stock granted to the CEO in connection to his annual bonus as set by the Board of Directors, that vested immediately.  The value of these shares when granted represents two times the value of a cash bonus that was due in March 2024, that the CEO elected to take in two times stock as per the Company’s policy for cash bonuses.

 

Share-based compensation expense was approximately $0.3 million and $1.2 million for the three and nine months ended September 30, 2024, respectively. Share-based compensation expense was approximately $0.3 million and $0.8 million for the three and nine months ended September 30, 2023, respectively.  As of September 30, 2024, future unrecognized stock compensation related to unvested shares totaled approximately $1.6 million.

 

 

13. SEGMENTS

 

The Company's reportable segments consist of three types of real estate properties for which the Company's decision-makers internally evaluate operating performance and financial results: Office/Industrial Properties, Model Home Properties and Retail Properties. The Company also has certain corporate-level activities, including accounting, finance, legal administration, and management information systems which are not considered separate operating segments. There is no material inter-segment activity.

 

The Company evaluates the performance of its segments based upon net operating income ("NOI"), which is a non-GAAP supplemental financial measure. The Company defines NOI for its segments as operating revenues (rental income, tenant reimbursements and other operating income) less property and related expenses (property operating expenses, real estate taxes, insurance, asset management fees and provision for bad debt) excluding interest expense. NOI excludes certain items that are not considered to be controllable in connection with the management of an asset such as non-property income and expenses, depreciation and amortization, real estate acquisition fees and expenses and corporate general and administrative expenses. The Company uses NOI to evaluate the operating performance of the Company's real estate investments and to make decisions about resource allocations.

 

27

 

The following tables compare the Company's segment activity to its results of operations and financial position as of and for the three and nine months ended September 30, 2024, and September 30, 2023:

 

  Three Months Ended September 30,  Nine Months Ended September 30, 
  

2024

  

2023

  

2024

  

2023

 

Office/Industrial Properties:

                

Rental, fees and other income

 $3,208,628  $2,928,103  $9,131,620  $8,810,167 

Property and related expenses

  (1,418,979)  (1,303,654)  (4,095,521)  (3,966,587)

Net operating income, as defined

  1,789,649   1,624,449   5,036,099   4,843,580 

Model Home Properties:

                

Rental, fees and other income

  1,002,831   1,093,778   3,427,200   2,970,940 

Property and related expenses

  (38,215)  (44,201)  (121,151)  (121,998)

Net operating income, as defined

  964,616   1,049,577   3,306,049   2,848,942 

Retail Properties:

                

Rental, fees and other income

  511,915   457,292   1,541,156   1,396,160 

Property and related expenses

  (140,821)  (125,623)  (437,415)  (391,772)

Net operating income, as defined

  371,094   331,669   1,103,741   1,004,388 

Reconciliation to net income:

                

Total net operating income, as defined, for reportable segments

  3,125,359   3,005,695   9,445,889   8,696,910 

General and administrative expenses

  (1,629,919)  (1,635,610)  (5,917,286)  (5,413,413)

Depreciation and amortization

  (1,455,882)  (1,351,705)  (4,158,270)  (4,054,109)

Impairment of real estate assets

  (697,146)     (893,939)   

Interest expense

  (1,473,528)  (1,375,199)  (4,514,579)  (3,579,381)

Loss on Conduit Pharmaceuticals marketable securities

  (3,932,770)  (17,682,154)  (17,821,437)  (17,682,154)

Gain on deconsolidation of SPAC

     40,321,483      40,321,483 

Other income, net

  5,263   254,486   15,116   1,394,687 

Income tax expense

  (6,911)  (134,620)  (167,496)  (632,147)

Gain on sale of real estate

  361,151   757,285   3,191,149   2,294,574 

Net income (loss)

 $(5,704,383) $22,159,661  $(20,820,853) $21,346,450 

 

28

 

 

  

September 30,

  

December 31,

 

Assets by Reportable Segment:

 

2024

  

2023

 

Office/Industrial Properties:

        

Land, buildings and improvements, net (1)

 $75,568,001  $77,472,724 

Total assets (2)

 $75,689,711  $78,140,372 

Model Home Properties:

        

Land, buildings and improvements, net (1)

 $40,082,995  $50,790,147 

Total assets (2)

 $40,392,853  $51,456,292 

Retail Properties:

        

Land, buildings and improvements, net (1)

 $15,760,917  $15,877,190 

Total assets (2)

 $16,580,539  $16,539,399 

Reconciliation to Total Assets:

        

Total assets for reportable segments

 $132,663,103  $146,136,063 

Other unallocated assets:

        

Cash, cash equivalents and restricted cash

  1,528,436   277,143 

Other assets, net

  11,653,691   29,549,432 

Total Assets

 $145,845,230  $175,962,638 

 

(1)

Includes lease intangibles.

 

(2)

Includes land, buildings and improvements, cash, cash equivalents, and restricted cash, current receivables, deferred rent receivables and deferred leasing costs and other related intangible assets, all shown on a net basis.

 

  

For the Nine Months Ended September 30,

 

Capital Expenditures by Reportable Segment

 

2024

  

2023

 

Office/Industrial Properties:

        

Capital expenditures and tenant improvements, office

 $1,462,957  $2,691,721 

Model Home Properties:

        

Acquisition of operating properties, model home

  9,729,351   13,715,923 

Retail Properties:

        

Capital expenditures and tenant improvements, retail

  211,321   126,065 

Totals:

        

Acquisition of operating properties, net

  9,729,351   13,715,923 

Capital expenditures and tenant improvements

  1,674,278   2,817,786 

Total real estate investments

 $11,403,629  $16,533,709 

  

 

14. INCOME TAX PROVISION

 

We have elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, commencing with the taxable year ended December 31, 2000. As a REIT, U.S. federal income tax law generally requires us to distribute annually at least 90% of our REIT taxable income, without regard to the deduction for dividends paid and excluding net capital gains, and that we pay tax at regular corporate rates to the extent that we annually distribute less than 100% of our net taxable income. We are also subject to U.S. federal, state and local income taxes on our domestic taxable REIT subsidiaries ("TRS") based on the tax jurisdictions in which they operate.

 

During the nine months ended September 30, 2024, we recorded a current income tax provision of $168,140 related to activities of our taxable REIT subsidiaries. There was a $346,762 income tax asset related to the operating activities of our TRS entities as of September 30, 2024 and December 31, 2023, as of each date respectively.

 

We have calculated the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the projected full fiscal year to the TRS pretax income or loss excluding unusual or infrequently occurring discrete items for the reporting period, and have accounted for the REIT's minimum state income taxes as a discrete item in the reporting period.

 
29

 

 

15. RELATED PARTY

 

During the three and nine months ended September 30, 2024 and three and nine months ended September 30, 2023, the Company leased portions of its corporate headquarters to Puppy Toes, Inc., a company owned by the Chief Executive Officer and his wife, and to Centurion Counsel, Inc., which is owned by Puppy Toes, Inc. Rent billed to these entities from the Company totaled $2,688 and $8,064 for the three and nine months ended September 30, 2024, respectively.  During the  three and nine months ended September 30, 2023, rent billed to these entities from the Company totaled $2,688  and $8,064, respectively.

 

Additionally, we receive full payroll reimbursement for employee services provided to Centurion Counsel and Puppy Toes, Inc. during the three and nine months ended September 30, 2024, which totaled approximately $32,611 and $108,326, respectively.  During the three and nine months ended September 30, 2023, full payroll reimbursement for these services totaled approximately $37,103 and $114,453, respectively. These reimbursements were at cost and were not marked up or discounted. As of September 30, 2024 and December 31, 2023, we had  reimbursement receivable balances of approximately $10,783 and $52,879, which were paid in full during October 2024 and January 2024, respectively.

 

 

16. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements were issued. Based upon this review, except as disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements other than disclosed below.

 

During October 2024, the Company paid part of an accrued bonus to the former CFO with shares of CDT common stock.  The total number of CDT common stock shares transferred to our former CFO was 1,045,805 shares at $0.1087 per share with a fair market value of $113,679 at the time of transfer.  After the transfer the Company still owns 2,944,514 shares of CDT common stock, 709,000 CDTTW warrants and 540,000 private warrants. 

 

The non-recourse loan on the Dakota Center matured on  July 6, 2024. Management has been in negotiations with the special servicer of the loan in modifying and/or extending the loan or possibly selling the building. We have not been able to come to an agreement regarding a situation in which the loan is modified or extended.  As such, in October 2024 we have offered the property for sale in conjunction with the lender’s approval  in attempts to make the lender whole, although there is no guarantee we will be able to do so.  The loan is considered non-recourse and we will not be required to make up the difference if the property sells for less than the loan balance.  See Note 4. Real Estate Asset above for further discussion on impairment of the property.

 

 

30

 
 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our consolidated financial statements and the notes thereto appearing in Item 1 of this report and the more detailed information contained in our 2023 year end Annual Report.

 

We may refer to the three months ended September 30, 2024, and September 30, 2023, as the "2024 Quarter" and the "2023 Quarter," respectively.

 

Forward-Looking Statements

 

This Form 10-Q contains forward-looking statements which involve risks and uncertainties. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as "may," "will," "should," "expects," "intends," "plans," "anticipates," "believes," "estimates," "predicts," or "potential" and/or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and also of which do not relate solely to historical matters. Such statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Moreover, investors are cautioned to interpret many of the risks identified in the risk factors discussed in this 10-Q and our 2023 year end Annual Report on Form 10-K/A for the year ended December 31, 2023, filed with the SEC on April 16, 2024, respectively. Additional factors which may cause the actual results, performance, or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements include, but are not limited to, the risks associated with the ownership of real estate in general and our real estate assets in particular; the economic health of the metro regions where we conduct business; the risk of failure to enter into/and or complete contemplated acquisitions and dispositions, within the price ranges anticipated and on the terms and timing anticipated; changes in the composition of our portfolio; fluctuations in interest rates; reductions in or actual or threatened changes to the timing of federal government spending; the risks related to the use of third-party providers and joint venture partners; the ability to control our operating expenses; the economic health of our tenants; the supply of competing properties; shifts away from brick and mortar stores to e-commerce; the availability and terms of financing and capital and the general volatility of securities markets; compliance with applicable laws, including those concerning the environment and access by persons with disabilities; terrorist attacks or actions and/or risks relating to information technology and cybersecurity attacks, loss of confidential information and other related business disruptions; weather conditions, natural disasters and pandemics; ability to maintain key personnel; failure to qualify and maintain our qualification as a REIT and the risks of changes in laws affecting REITs; and other risks and uncertainties detailed from time to time in our filings with the SEC, including our 2023 year end Annual Report. While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. We undertake no obligation to update our forward-looking statements or risk factors to reflect new information, future events, or otherwise.

 

OVERVIEW

 

The Company operates as an internally managed, diversified REIT, with primary holdings in office, industrial, retail, and triple-net leased model home properties. In October 2017, we changed our name from "NetREIT, Inc." to "Presidio Property Trust, Inc." The Company acquires, owns, and manages a geographically diversified portfolio of real estate assets, including office, industrial, retail and model home residential properties leased to homebuilders located in the United States. As of September 30, 2024, the Company owned or had an equity interest in:

 

 

Eight office buildings and one industrial property ("Office/Industrial Properties"), which total approximately 758,175 rentable square feet;

 

 

Three retail shopping centers ("Retail Properties"), which total approximately 65,242 rentable square feet; and

 

 

83 model home residential properties ("Model Homes" or "Model Home Properties"), totaling approximately 251,602 square feet, leased back on a triple-net basis to homebuilders that are owned by five affiliated limited partnerships and one wholly-owned corporation, all of which we control.

 

31

 

We own five commercial properties located in Colorado, four in North Dakota, one in Southern California, one in Texas and one in Maryland. Our model home properties are located in three states.  While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas. We do not develop properties but acquire properties that are stabilized or that we anticipate will be stabilized within two or three years of acquisition. We consider a property to be stabilized once it has achieved an 80% occupancy rate for a full year as of January 1 of such year or has been operating for three years.

 

Most of our office and retail properties are leased to a variety of tenants ranging from small businesses to large public companies, many of which are not investment grade. We have, in the past, entered into, and intend in the future to enter into, purchase agreements for real estate having net leases that require the tenant to pay all of the operating expenses or pay increases in operating expenses over specific base years. Most of our office leases are for terms of three to five years with annual rental increases. Our model homes are typically leased back for two to three years to the home builder on a triple-net lease. Under a triple-net lease, the tenant is required to pay all operating, maintenance and insurance costs and real estate taxes with respect to the leased property.

 

We seek to diversify our portfolio by commercial real estate segments, including office, industrial, retail and model home properties to reduce the adverse effect of a single under-performing segment and/or tenant. We further mitigate risk at the tenant level through our credit review process, which varies by tenant class. For example, our commercial and industrial tenants tend to be corporations or individually owned businesses. In these cases, we typically obtain financial records, including financial statements and tax returns (depending on the circumstance), and run credit reports for any prospective tenant to support our decision to enter into a rental arrangement. We also typically obtain security deposits from these commercial tenants. Our Model Home commercial tenants are well-known homebuilders with established credit histories. These tenants are subjected to financial review and analysis prior to us entering into a sales-leaseback transaction.

 

In June 2024, the Board of Directors established the Strategic Planning and Cyber Committee (the "Strategic Committee").   The purpose of the Strategic Committee is to: assist the Board in carrying out its responsibilities of oversight over the Company's business strategy, make recommendations to the Board on the Company's strategic direction and objectives and serve as a liaison between the Board and management, and assist the Board in fulfilling its responsibilities of oversight with regard to the Company's identification, assessment, and management of the Company's cybersecurity risks. There can be no assurance that the work of the Strategic Committee will result in any transaction being pursued or consummated. In addition, there is no formal timetable for the Strategic Committee's exploration of potential strategic alternatives, and the Company does not intend to disclose any developments with respect to the Strategic Committee's activities unless and until the Company determines that further disclosure is appropriate or required by law or regulation.

 

For additional information regarding our Common Stock activity, see Footnote 12. Stockholders' Equity in the Notes to the Consolidated Financial Statements in "Part I, Item 1. Financial Statements" of this Quarterly Report.

 

For details regarding our sponsorship of a special purpose acquisition company, Murphy Canyon Acquisition Corp. ("Murphy Canyon" or the "SPAC"), see Note 9, Investment in Conduit Pharmaceuticals, in the Notes to the Consolidated Financial Statements in "Part I, Item 1. Financial Statements" of this Quarterly Report.

 

SIGNIFICANT TRANSACTIONS IN 2024 AND 2023

 

Acquisitions during the nine months ended September 30, 2024
 
 

The Company acquired 19 model homes for approximately $9.7 million. The purchase price was paid through cash payments of approximately $3.0 million and mortgage notes of approximately $6.7 million.

 

Acquisitions during the nine months ended September 30, 2023
 
 

The Company acquired 25 model homes for approximately $13.7 million.  These acquisitions were paid for with approximately $4.2 million in cash payments and approximately $9.5 million in mortgage loans.  There were no other commercial properties acquired during this period.

 

32

 

Dispositions during the nine months ended September 30, 2024

 

 

The Company sold 46 model homes for approximately $22.3 million, net of sales costs, and recognized a gain of approximately $3.2 million.

 

Dispositions during the nine months ended September 30, 2023
 
 

The Company sold 15 model homes for approximately $7.8 million, net of sales costs, and recognized a gain of approximately $2.3 million.

 

CRITICAL ACCOUNTING POLICIES

 

There have been no material changes to our critical accounting policies as previously disclosed in our 2023 year end Annual Report.

 

MANAGEMENT EVALUATION OF RESULTS OF OPERATIONS

 

Management’s evaluation of operating results includes an assessment of our ability to generate the cash flow necessary to pay operating expenses, general and administrative expenses, debt service and to fund distributions to our stockholders. As a result, management’s assessment of operating results gives less emphasis to the effects of unrealized gains and losses and other non-cash charges, such as depreciation and amortization and impairment charges, which may cause fluctuations in net income for comparable periods but have no impact on cash flows. Management’s evaluation of our potential for generating cash flow includes assessments of our recently acquired properties, our non-stabilized properties, long-term sustainability of our real estate portfolio, our future operating cash flow from anticipated acquisitions, and the proceeds from the sales of our real estate assets.

 

In addition, management evaluates the results of the operations of our portfolio and individual properties with a primary focus on increasing and enhancing the value, quality and quantity of properties in our real estate holdings. Management focuses its efforts on improving underperforming assets through re-leasing efforts, including negotiation of lease renewals and rental rates. Properties are regularly evaluated for potential added value appreciation and cashflow and, if lacking such potential, are sold with the equity reinvested in new acquisitions or otherwise allocated in a manner we believe is accretive to our stockholders. Our ability to increase assets under management is affected by our ability to raise borrowings and/or capital, coupled with our ability to identify appropriate investments.

 

 

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED September 30, 2024 and 2023

 

Revenues. Total revenues were approximately $4.7 million for the three months ended September 30, 2024, compared to approximately $4.5 million for the same period in 2023.  As of September 30, 2024, we had approximately $131.4 million in net real estate assets including 83 model homes, compared to approximately $138.4 million in net real estate assets including 102 model homes at September 30, 2023.  The change in revenue is directly related to the new commercial real estate leases at Grand Pacific Center, and model home transaction fees earned by the Company during the current period, slightly offset by the reduction in model home income during the current quarter.

 

Rental Operating Costs. Rental operating costs increased 8.1%, totaling approximately $1.6 million for the three months ended September 30, 2024, compared to approximately $1.5 million for the same period in 2023, due to the increased cost of operating our commercial properties. Rental operating costs as a percentage of total revenue was 33.8% and 33.0% for the three months ended September 30, 2024 and 2023, respectively.  As of September 30, 2024, our model home assets made up 30.5% of our total real estate assets, which is down from 33.2% as of September 30, 2023.  Model home rental operating costs are relatively low for model home assets as they are leased on a triple net basis. Additionally, for the three months ended September 30, 2024, our gross revenue from model home assets represented approximately 21.2% of our total revenue, compared to 24.4% for the three months ended September 30, 2023.  This percentage is expected to decrease in 2024 as a large number of model homes were sold during the three and nine months ended September 30, 2024.  There were no acquisitions or sales of retail, office or industrial properties during the three months ended September 30, 2024; however, management is selling two of our commercial real estate assets, totaling approximately $11.1 million, over the next 12 months, which will reduce future rental income until those proceeds are reinvested. 

 

General and Administrative Expenses. General & Administrative (“G&A”) expenses for the three months ended September 30, 2024 and 2023 totaled approximately $1.6 million and $1.6 million, respectively. G&A expenses as a percentage of total revenue was 34.5% and 36.5% for the three months ended September 30, 2024 and 2023, respectively.  G&A expenses was relatively flat for the three months ended September 30, 2024 when compared to the three months ended September 30, 2023.  

 

33

 

Depreciation and Amortization. Depreciation and amortization expense was approximately $1.5 million for the three months ended September 30, 2024, compared to approximately $1.4 million for the same period in 2023.

 

Asset Impairments. We review the carrying value of each of our real estate properties regularly to determine if circumstances indicate an impairment in the carrying value of these investments exists. During the three months ended September 30, 2024, we recognized a non-cash impairment charge of approximately $0.7 million related to three model homes and one commercial property. The impairment on our commercial property, Dakota Center, was the result of the loan maturing in July and the Company not being able to reach an agreement with the lenders regarding a loan modification or extension. In October the lender has agreed to a sale of the property to settle the balance of the non-recourse loan. Due to the uncertainties in the Fargo market, we decided to impair the property’s book value, in accordance with ASC 360-10 impairment of long-lived assets.  As such, we recorded an impairment charge of approximately $0.7 million as of September 31, 2024. The new impairment charges for the three model homes reflects the estimated sales prices for these specific model homes in October and November 2024 as a result of an abnormally short hold period, less than two years, on model homes purchased in 2022.  The builder changed their product style in the neighborhoods where these model homes are located, in Texas, after we had purchased the homes.  We do not believe these losses are indicative of our overall model home portfolio.  During the three months ended September 30, 2024, we sold four model homes for approximately $2.2 million and the Company recognized a net gain of approximately $0.4 million.  We expect to record a net gain on model home sales in the fourth quarter of 2024 as well. The Company did not recognize a non-cash impairment to our real estate assets during the three months ended September 30, 2023.

 

Interest Expense - mortgage notes. Interest expense, including amortization of deferred finance charges was approximately $1.5 million for the three months ended September 30, 2024, compared to approximately $1.4 million for the same period in 2023. The weighted average interest rate on our outstanding debt was 5.44% and 5.06% as of September 30, 2024 and 2023, respectively.  Mortgage notes payable totaled approximately $103.2 million and $103.3 million as of September 30, 2024 and 2023, respectively.

 

Gain on Sale of Real Estate Assets, net. The change in gain or loss on the sale of real estate assets is dependent on the mix of properties sold and the market conditions at the time of the sale. During the three months ended September 30, 2024, we sold four model homes for approximately $2.2 million, net of selling costs, and the Company recognized a net gain of approximately$0.4 million.  We expect to record a net gain on model home sales in the fourth quarter of 2024 as well.  During the three months ended September 30, 2023, we sold five model homes for approximately $2.5 million, net of selling costs, and the Company recognized a net gain of approximately $0.8 million.

 

Income allocated to non-controlling interests. Income allocated to non-controlling interests for the three months ended September 30, 2024 and 2023 totaled approximately $0.4 million and $0.7 million, respectively.

 

Loss on Conduit remeasurement. On April 22, 2024, the Company entered into a lockup agreement with Conduit pursuant to which the Company agreed not to transfer or sell 2,700,000 of its 4,015,250 shares of Conduit common stock for a period of one year.  In consideration for entering into the lockup agreement, Conduit issued the Company a warrant ("Private CDT Warrants") to purchase 540,000 shares of common stock at an exercise price of $3.12 per share, with a two year term and exercisable one year after the date of issue.  The Private CDT Warrants meet the ASC 321 scope exception for derivative instruments and are accounted for as a derivative under ASC 815. As such, the Private CDT Warrants were recorded at fair value on the date of issuance and subsequently measured at fair value each period, with changes in fair value reported in gain or loss on Conduit Pharmaceuticals marketable securities.  As of June 30 2024, the Private CDT Warrants were valued at $156,000 based on a Level 3 fair value measurement.  As of September 30, 2024, the Private CDT Warrants fair value was adjusted to zero, which is included in the total Investment in Conduit Pharmaceuticals marketable securities on the September 30, 2024 consolidated balance sheet.  Our investments in Conduit's common stock (3,990,319 shares of CDT) and public common stock warrants (709,000 warrants of CDTTW) presented on the consolidated balance sheets were measured at fair value using Level 1 market prices, taking into account the adoption of ASU 2022-03 Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, and totaled approximately $0.5 million as of September 30, 2024. The combined value of our Investment in Conduit Pharmaceuticals marketable securities, including the Private CDT Warrants, totaled $0.5 million as of September 30, 2024.  In connection with these fair market value adjustments during the three months ended September 30, 2024, we recorded a net loss on our investment in Conduit of approximately $3.9 million.

 

RESULTS OF OPERATIONS FOR THE nine MONTHS ENDED September 30, 2024 and 2023

 

Revenues. Total revenues were approximately $14.1 million for the nine months ended September 30, 2024, compared to approximately $13.1 million for the same period in 2023.  As of September 30, 2024, we had approximately $131.4 million in net real estate assets including 83 model homes, compared to approximately $138.4 million in net real estate assets including 102 model homes at September 30, 2023.  The average number of model homes held during the nine months ended September 30, 2024 and 2023 was 84 and 102, respectively. The change in revenue is directly related to the increase in model home transaction fees during the current period, new commercial real estate leases, mainly at Grand Pacific Center, and the management fees earned from Conduit Pharma during the current period, which was terminated in June 2024.  Below is additional revenue and asset information for real estate segments as of September 30, 2024.

 

34

 

 

   

% of Gross Revenue

 
   

For the Nine Months Ended September 30,

 
   

2024

   

2023

 

Segment

               

Office/Industrial

    64.8 %     66.9 %

Retail

    10.9 %     10.6 %

Model Home

    24.2 %     22.5 %

 

   

% of Total Real Estate Assets as of

 
   

September 30,

   

December 31,

 
   

2024

   

2023

 

Segment (1)

               

Office/Industrial

    57.5 %     55.3 %

Retail

    12.0 %     11.5 %

Model Home

    30.5 %     33.2 %

 

(1) Includes lease intangibles and the land purchase option related to property acquisitions.

 

Rental Operating Costs. Rental operating costs were slightly higher totaling $4.7 million for the nine months ended September 30, 2024, compared to approximately $4.5 million for the same period in 2023. Rental operating costs as a percentage of total revenue was 33.0% and 33.9% for the nine months ended September 30, 2024 and 2023, respectively.  As of September 30, 2024, our model home assets made up 30.5% of our total real estate assets, which is down from 33.2% as of September 30, 2023.  Model home rental operating costs are relatively low for model home assets as they are leased on a triple net basis. Additionally, for the nine months ended September 30, 2024, our gross revenue from model home assets represented approximately 24.2% of our total revenue, compared to 22.5% for the nine months ended September 30, 2023.  This percentage is expected to decrease in 2024 as a large number of model homes were sold during the nine months ended September 30, 2024.  There were no acquisitions or sales of retail, office or industrial properties during the nine months ended September 30, 2024; however, management is selling two of our commercial real estate assets, totaling approximately $11.1 million, over the next 12 months, which will reduce future rental income until those proceeds are reinvested. 

 

General and Administrative Expenses. G&A expenses for the nine months ended September 30, 2024 and 2023 totaled approximately $5.9 million and $5.4 million, respectively. G&A expenses as a percentage of total revenue was 42.0% and 41.2% for the nine months ended September 30, 2024 and 2023, respectively.  G&A expenses increased by approximately $0.5 million mainly related to the 2024 annual meeting and settlement with Zuma Capital and certain individuals and entities affiliated or associated with Zuma Capital Management, LLC (Zuma Capital").  This included additional consulting fees, higher proxy solicitation fees and legal fees, which increased by an aggregate of approximately $0.6 million in 2024 as compared to 2023.  Additionally, stock compensation and bonus accruals increased during the nine months ended September 30, 2024 by approximately $0.5 million as compared to the same period in 2023 related to De-SPAC success bonuses to current and former employees. This was slightly offset by the reduction in salaries and employees cost by approximately $0.2 million in 2024 as compared to 2023, and the approximately $0.2 million reduction of D&O insurance related to the SPAC in 2023 that was not consolidated during 2024.

 

Depreciation and Amortization. Depreciation and amortization expense was approximately $4.2 million and $4.1 million for the nine months ended September 30, 2024 and 2023, respectively.

 

Asset Impairments. We review the carrying value of each of our real estate properties regularly to determine if circumstances indicate an impairment in the carrying value of these investments exists. During the nine months ended September 30, 2024, we recognized a non-cash impairment charge of approximately $0.9 million related to model homes and one commercial property. The impairment on our commercial property, Dakota Center, was the result of the loan maturing in July and the Company not being able to reach an agreement with the lenders regarding a loan modification or extension. In October the lender has agreed to a sale of the property to settle the balance of the non-recourse loan. Due to the uncertainties in the Fargo market, we decided to impair the property’s book value, in accordance with ASC 360-10 impairment of long-lived assets and for long-lived assets to be disposed of, to be in line with the current loan balance and estimated closing costs, which is the expected sales price.  As such, we recorded an impairment charge of approximately $0.7 million, as of September 31, 2024. The new impairment charges for the model homes reflects the estimated and actual sales prices for these specific model homes that were sold after the end of each quarter.  This was the result of an abnormally short hold period, less than two years, on model homes purchased in 2022.  The builder changed their product style in the neighborhoods where these model homes are located, in Texas, after we had purchased the homes.  We do not believe these losses are indicative of our overall model home portfolio.  During the nine months ended September 30, 2024, we sold 46 model homes for approximately $22.3 million, net of sales costs, and the Company recognized a net gain of approximately $3.2 million.  We expect to record a net gain on model home sales in the fourth quarter of 2024 as well. The Company did not recognize a non-cash impairment to our real estate assets during the nine months ended September 30, 2023.

 

Interest Expense - mortgage notes. Interest expense, including amortization of deferred finance charges was approximately $4.5 million for the nine months ended September 30, 2024compared to approximately $3.6 million for the same period in 2023. The weighted average interest rate on our outstanding debt was 5.44% and 5.06% as of September 30, 2024 and 2023, respectively.  Mortgage notes payable totaled approximately $103.2 million and $103.3 million as of September 30, 2024 and 2023, respectively.

 

35

 

Gain on Sale of Real Estate Assets, net.  The change in gain or loss on the sale of real estate assets is dependent on the mix of properties sold and the market conditions at the time of the sale. S ee "Significant Transactions in 2024 and 2023 " above for further detail.

 

Income allocated to non-controlling interests.  Income allocated to non-controlling interests for the nine months ended September 30, 2024  and  2023  totaled approximately $2.3 million and $2.2 million, respectively.  This was directly related to the gain on sales of model homes held by  our five affiliated limited partnerships.

 

Loss on Conduit remeasurement. On April 22, 2024, the Company entered into a lockup agreement with Conduit pursuant to which the Company agreed not to transfer or sell 2,700,000 of its 4,015,250 shares of Conduit common stock for a period of one year.  In consideration for entering into the lockup agreement, Conduit issued the Company Private CDT Warrants to purchase 540,000 shares of common stock at an exercise price of $3.12 per share, a two year term and  exercisable one year after the date of issue.  The Private CDT Warrants meet the ASC 321 scope exception for derivative instruments and are accounted for as a derivative under ASC 815. As such, the Private CDT Warrants were recorded at fair value on the date of issuance and subsequently measured at fair value each period, with changes in fair value reported in gain or loss on Conduit Pharmaceuticals marketable securities.  As of April 22, 2024, the Private CDT Warrants were valued at $891,000 based on a Level 3 fair value measurement.  As of  September 30, 2024, the Private CDT Warrants fair value was adjusted to zero, which is included in the total Investment in Conduit Pharmaceuticals marketable securities on the September 30, 2024 consolidated balance sheet.  Our investments in Conduit's common stock (3,990,319 shares of CDT) and public common stock warrants (709,000 warrants of CDTTW) presented on the consolidated balance sheets were measured at fair value using Level 1 market prices, taking into account the adoption of ASU 2022-03 Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, and totaled approximately $0.5 million as of September 30, 2024. The combined value of our Investment in Conduit Pharmaceuticals marketable securities, including the Private CDT Warrants, totaled $0.5 million as of September 30, 2024. Our investments in Conduit's common stock and public common stock warrants presented on the consolidated balance sheet were measured at fair value using Level 1 market prices as of  December 31, 2023, and totaled approximately  $18.3 million.  In connection with these fair market value adjustments during the  nine months ended September 30, 2024, we recorded a net loss on our investment in Conduit of approximately $17.8 million.  We will realize a portion of the loss during the fourth quarter of 2024.  During October 2024, the Company paid part of an accrued bonus to the former CFO with shares of CDT common stock.  The total number of CDT common stock shares transferred to our former CFO was 1,045,805 shares at $0.1087 per share with a fair market value of $113,679 at the time of transfer.  After the transfer the Company still owns 2,944,514 shares of CDT common stock, 709,000 CDTTW warrants and 540,000 private warrants. 

 

Geographic Diversification Tables

 

The following tables show a list of commercial properties owned by the Company grouped by state and geographic region as of September 30, 2024:

 

State

 

No. of Properties

   

Aggregate Square Feet

   

Approximate % of Square Feet

   

Current Base Annual Rent

   

Approximate % of Aggregate Annual Rent

 

California

    1       57,807       7.0 %   $ 1,515,541       13.0 %

Colorado

    5       324,245       39.4 %     5,507,742       47.3 %

Maryland

    1       31,752       3.9 %     724,453       6.2 %

North Dakota

    4       399,113       48.4 %     3,554,545       30.6 %

Texas

    1       10,500       1.3 %     342,692       2.9 %

Total

    12       823,417       100.0 %   $ 11,644,973       100.0 %

 

The following tables show a list of our Model Home properties by geographic region as of September 30, 2024:

 

State

 

No. of Properties

   

Aggregate Square Feet

   

Approximate % of Square Feet

   

Current Base Annual Rent

   

Approximate of Aggregate % Annual Rent

 

Arizona

    2       6,822       2.7 %   $ 149,196       4.2 %

Florida

    4       9,875       3.9 %     170,256       4.8 %

Texas

    77       234,905       93.4 %     3,248,760       91.0 %

Total

    83       251,602       100.0 %   $ 3,568,212       100.0 %

 

 

36

 

LIQUIDITY AND CAPITAL RESOURCES

 

Overview

 

Our anticipated future sources of liquidity may include existing cash and cash equivalents, cash flows from operations, refinancing of existing mortgages, future real estate sales, new borrowings from our model home lines of credit, the sale of our investment in Conduit Pharma, and the sale of our equity or issuance of debt securities or bonds.   Our cash and restricted cash at September 30, 2024 was approximately $7.2 million. Our future capital needs include paying down existing borrowings, maintaining our existing properties, funding tenant improvements, paying lease commissions (to the extent they are not covered by lender-held reserve deposits), and the payment of dividends to our stockholders. We also are actively seeking model home investments that are likely to produce income and achieve long-term gains in order to pay dividends to our stockholders. To ensure that we can effectively execute these objectives, we routinely review our liquidity requirements and continually evaluate all potential sources of liquidity.

 

Our short-term liquidity needs include paying our current operating costs, satisfying the debt service requirements of our existing mortgages, completing tenant improvements, paying leasing commissions, and funding dividends to stockholders.  Future principal payments due on our mortgage notes payables during 2024 total approximately $11.7 million, of which approximately $2.3 million is related to model home properties.  During the next 12 months, five commercial property loans, in addition to the Dakota Center which matured in July 2024, for Research Parkway, Arapahoe Service Center, Union Town Center, One Park, and Genesis Plaza, have mortgage loans that will mature totaling approximately $28.4 million. The loan on the Dakota Center matured on July 6, 2024.  Management was in negotiations with the special servicer of the loan in modifying and/or extending; however no agreement could be reached and in October we had agreed with the lender to sell the property in order to settle the balance on the non-recourse loan.  The Company and the lender are currently reviewing real estate brokers to sell the property on the open market with the hopes of obtaining the best sales price; however there can be no guarantee the property will sell for more than the loan balance.

 

Management has begun discussions with various lenders to either restructure, extend or refinance the other three loans.  Additionally, management may consider selling these properties if we are unsuccessful in extending the maturity dates or are unable to raise additional funds to pay these non-recourse loans in full.  Only the loan on Research Parkway, for $1.6 million has recourse to the Company.  Management expects certain model homes will be sold, and that the underlying mortgage notes will be paid off with sales proceeds, while other mortgage notes will be refinanced as the Company has done in the past. Additional principal payments will be made with cash flows from ongoing operations.  On December 31, 2022, the lease for our largest tenant at that time, Halliburton, expired.  Halliburton was located in our Shea Center II property in Colorado and did not renew the lease.  We placed approximately $1.1 million in a reserve account with our lender to cover future mortgage payments, if necessary, in connection with Halliburton's vacant space, none of which has been used as of  December 31, 2023. This reserve amount is included in "Cash, cash equivalents and restricted cash" on the consolidated balance sheet.  Our management team is working to fill the 45,535 square foot space and has leased approximately 35% of the space to a tenant during 2023 and 2024 and has reviewed various third party proposals for the remaining 65%.  As of September 30, 2024, management is pursuing third party tenants who fit into our long-term plans, however, there is no guarantee we will be successful in signing these new tenants.

 

While we will continue to pursue value creating investments, the Board of Directors believes there is significant embedded value in our assets that is yet to be realized by the market. Therefore, returning capital to stockholders through a repurchase program is an attractive use of capital currently.  On September 15, 2022, the Board of Directors authorized a stock repurchase program of up to $6.0 million of outstanding shares of our Series A Common Stock and up to $4.0 million of our Series D Preferred Stock, which expired in September 2023. In November 2023, the Board of Directors authorized a stock repurchase program of up to $6.0 million of outstanding shares of our Series A Common Stock and up to $4.0 million of our Series D Preferred Stock which shall expire in November 2024. During the year ended December 31, 2023, the Company repurchased 23,041 shares of our Series D Preferred Stock at an average price of approximately $16.06 per share, including a commission of $0.035 per share, and no shares of our Series A Common Stock, for a total cost of $0.4 million for the Series D Preferred Stock. During the nine months ended September 30, 2024, we repurchased 137,709 shares of our Series A Common Stock, for a total cost of $97,394, with an average price of approximately $0.7072 per share. There were no repurchases of Series D Preferred Stock during the nine months ended September 30, 2024. Any repurchased shares are treated as authorized and unissued in accordance with Maryland law and shown as a reduction of stockholders’ equity at cost.

 

There can be no assurance that the Company will refinance loans, take out additional financing or capital will be available to the Company on acceptable terms, if at all. If events or circumstances occur such that the Company does not obtain additional funding, it will most likely be required to reduce its plans, reduce certain discretionary spending or even sell properties, which could have a material adverse effect on the Company’s ability to achieve its intended business objectives. We believe that cash on hand, cash flow from our existing portfolio, distributions from joint ventures in Model Home Partnerships and property sales during 2024 and 2025 will be sufficient to fund our operating costs, planned capital expenditures and required dividends for at least the next twelve months. If our cash flow from operating activities is not sufficient to fund our short-term liquidity needs, we plan to fund a portion of these needs from additional borrowings of secured or unsecured indebtedness, from real estate sales, issuance of debt instruments, additional investors, or we may reduce or suspend the rate of dividends to our stockholders.

 

37

 

Our long-term liquidity needs include the capital necessary to grow and maintain our portfolio of investments. We believe that the potential financing capital available to us in the future is sufficient to fund our long-term liquidity needs. We are continually reviewing our existing portfolio to determine which properties have met our short- and long-term goals and while seeking to reinvest the proceeds in properties with better potential to increase performance. We expect to obtain additional cash in connection with refinancing of maturing mortgages and assumption of existing debt collateralized by some or all of our real property in the future to meet our long-term liquidity needs. If we are unable to arrange a line of credit, borrow on properties, privately place securities or sell securities to the public, we may not be able to acquire additional properties to meet our long-term objectives.

 

For the three and nine months ended September 30, 2024, the Company has not declared a cash dividend for the Series A Common stockholders. For the three and nine months ended September 30, 2023, the Company declared and paid approximately $0.3 million and $0.9 million in a cash dividend, respectively.  For the three and nine months ended September 30, 2024, the Company declared and paid approximately $0.6 million  and $1.7 million in monthly cash dividends, respectively for the Series D Preferred stockholders. For the three and nine months ended September 30, 2023, the Company declared and paid approximately $0.5 million and $1.6 million  in monthly cash dividends, respectively. 

 

The Company is reviewing when it may pay dividends to our common stockholders on a quarterly basis again, cash permitting, and intends to continue on a monthly basis to pay dividends to holders of our Series D Preferred Stock going forward, but there can be no guarantee the Board of Directors will approve any future dividends. The Company is still considering how much it may declare during 2024 on the Series A Common Stock, as there was no cash dividend declared or paid during the nine months ended September 30, 2024.  The following is a summary of distributions declared per share of our Series A Common Stock and for our Series D Preferred Stock for the nine months ended September 30, 2024 and 2023.

 

Series A Common Stock:

 

Quarter Ended

 

2024

   

2023

 
   

Distributions Declared

   

Distributions Declared

 

March 31

  $ -     $ 0.022  

June 30

    -       0.023  

September 30

    -       0.023  

Total

  $ -     $ 0.045  

 

Series D Preferred Stock:

 

Month

 

2024

   

2023

 
   

Distributions Declared

   

Distributions Declared

 

January

  $ 0.19531     $ 0.19531  

February

    0.19531       0.19531  

March

    0.19531       0.19531  

April

    0.19531       0.19531  

May

    0.19531       0.19531  

June

    0.19531       0.19531  

July

    0.19531       0.19531  

August

    0.19531       0.19531  

September

    0.19531       0.19531  

Total

  $ 1.75779     $ 1.75779  

 

38

 

Our long-term liquidity needs include the proceeds necessary to grow and maintain our portfolio of investments. We believe that the potential financing capital available to us in the future is sufficient to fund our long-term liquidity needs. We are continually reviewing our existing portfolio to determine which properties have met our short- and long-term goals and while seeking to reinvest the proceeds in properties with better potential to increase performance. We expect to obtain additional cash in connection with refinancing of maturing mortgages and assumption of existing debt collateralized by some or all of our real property in the future to meet our long-term liquidity needs. If we are unable to arrange a line of credit, borrow on properties, issue debt instruments, privately place securities or sell securities to the public, we may not be able to acquire additional properties to meet our long-term objectives. 

 

Cash Equivalents and Restricted Cash

 

At September 30, 2024, and December 31, 2023, we had approximately $7.2 million and $6.5 million in cash equivalents, respectively, including $3.5 million and $3.7 million of restricted cash, respectively. Our cash equivalents and restricted cash consist of invested cash, cash in our operating accounts, short-term bonds and cash held in bank accounts at third-party institutions. During 2024 and 2023, we did not experience any loss or lack of access to our cash or cash equivalents. Approximately $1.5 million to 2.0 million of our cash balance is intended for capital expenditures on existing properties, net of any construction financing (some of which is held in deposits reserve accounts by our lenders) during the rest of the year. We intend to use the remainder of our existing cash and cash equivalents for asset/property acquisitions, reduction of principal debt, general corporate purposes, common stock repurchases (if market conditions are met), or dividends to our stockholders. 

 

Secured Debt

 

As of September 30, 2024, all our commercial properties, except 300 N.P. which has no debt, had fixed-rate mortgage notes payable in the aggregate principal amount of  $75.6 million, collateralized by a total of  11 commercial properties with loan terms at issuance ranging from 5 to 10 years. The weighted-average interest rate on these mortgage notes payable as of September 30, 2024, was approximately 4.97%, and our debt to estimated market value for our commercial properties was approximately  65.2%.  During the next 12 months, five of our commercial property loans, totaling approximately $28.4 million, will mature, with an estimated combined loan to value of approximately 59.6% as of September 30, 2024. The non-recourse loan on the Dakota Center property matured on July 6, 2024.  During October 2024, management has agreed with the lender to sell the property to settle the loan balance.  Due to the uncertainties in the Fargo market, we have decided to impair the property’s book value, in accordance with ASC 360-10 impairment of long-lived assets and for long-lived assets to be disposed of, to be in line with the current loan balance and estimated closing costs, which is the expected sales price.  As such, we recorded an impairment charge of approximately $0.7 million, as of  September 30, 2024.

 

As of September 30, 2024, the Company had fixed-rate mortgage notes payable related to model homes in the aggregate principal amount of $27.5 million, excluding loans eliminated through consolidation, collateralized by a total of 82 Model Homes.  These loans generally have a term at issuance of three to five years. As of September 30, 2024, the average loan balance per home outstanding and the weighted-average interest rate on these mortgage loans are approximately $335,826 and 6.74%, respectively. Our debt to estimated market value on all our model home properties is approximately 56.0%, excluding any loans eliminated through consolidation.  We have been able to refinance maturing mortgages to extend maturity dates and we have not experienced any notable difficulties financing our acquisitions.  The Company anticipates that any new mortgages used to acquire commercial properties or model homes in the near future will be at rates higher than our currently weighted average interest rate. As of September 30, 2024, we had issued one promissory note to our majority owned subsidiary, Dubose Model Home Investors 202 LP, for the refinancing of one model home property in Texas, for approximately $0.3 million with an interest rate of 5.55% per annum and original maturity date of August 15, 2024, which was extended for another year with an interest rate of 8.0% per annum. This note payable and note receivable, including interest expense and interest income related to this promissory note, is eliminated through consolidation on our financial statements.  This property was subsequently sold in October 2024, and the loan was paid in full.

 

Cash Flow for the nine months ended September 30, 2024, and September 30, 2023

 

Operating Activities: Net cash used in operating activities for the nine months ended September 30, 2024, totaled approximately $1.0 million, as compared to cash used in operating activities of $0.4 million for the nine months ended September 30, 2023. The change in net cash used in operating activities is mainly due to changes in net income, which fluctuates due to new leases, leasing renewals, tenant move outs and model home sales and acquisitions, as well as changes in non-cash addbacks or subtractions such as straight-line rent.

 

Investing Activities: Net cash provided by investing activities for the nine months ended September 30, 2024, was approximately $10.7 million compared to approximately $129.0 million used in investing activities during the same period in 2023. The change from each period was primarily related to the gross cash withdrawal of approximately $114.1 million during the first quarter of 2023 for SPAC redemptions.  There were no similar transactions during the nine months ended September 30, 2024.  Proceeds from the sale of real estate assets total approximately $22.3 million, net of selling costs, while cash used in real estate acquisition and capital improvement totaled approximately $11.7 million, for the nine months ended September 30, 2024.

 

39

 

We currently project that we could spend up to $1.5 million to $2.0 million (some of which is held in deposits reserve accounts by our lenders) on capital improvements, tenant improvements and leasing costs for properties within our portfolio during the next 12 months. Capital expenditures may fluctuate in any given period subject to the nature, extent, and timing of improvements required to the properties. We may spend more on capital expenditures in the future due to rising construction costs. Tenant improvements and leasing costs may also fluctuate in any given year depending upon factors such as the property, the term of the lease, the type of lease, the involvement of external leasing agents and overall market conditions.

 

Financing Activities: Net cash used in financing activities during the nine months ended September 30, 2024, was $8.9 million compared to $137.4 million provided by financing activities for the same period in 2023 and was primarily due to the following activities for the nine months ended September 30, 2024:

 

  Proceeds from mortgage notes payable, net of issuance costs totaled approximately $13.6 million.
     
  Proceeds from the issuance of Series D Preferred Stock, net of offering costs, totaled approximately $1.2 million.
     
  Repayment of mortgage notes payable totaled approximately $18.9 million for the nine months ended September 30, 2024.
     
  Distributions to noncontrolling interest of approximately $3.1 million for the nine months ended September 30, 2024.
     
  Dividends paid to Series D Preferred Stockholders of approximately $1.7 million for the nine months ended September 30, 2024.
     

 

Off-Balance Sheet Arrangements

 

On July 12, 2021, the Company entered into a securities purchase agreement with a single U.S. institutional investor for the purchase and sale of 1,000,000 shares of its Series A Common Stock, Common Stock Warrants to purchase up to 2,000,000 shares of Series A Common Stock and Pre-Funded Warrants to purchase up to 1,000,000 shares of Series A Common Stock. Each share of Common Stock and accompanying Common Stock Warrants were sold together at a combined offering price of $5.00, and each share of Common Stock and accompanying Pre-Funded Warrant were sold together at a combined offering price of $4.99. The Pre-Funded Warrants were exercised in full during August 2021 at a nominal exercise price of $0.01 per share. The Common Stock Warrants have an exercise price of $5.50 per share, exercisable upon issuance and will expire five years from the date of issuance. 

 

In connection with this additional offering, we agreed to issue the Placement Agent Warrants to purchase up to 80,000 shares of Series A Common Stock, representing 4.0% of the Series A Common Stock and shares of Series A Common Stock issuable upon exercise of the Pre-Funded Warrants.  The Placement Agent Warrants were issued in August 2021, post exercise of the Pre-Funded Warrants with an exercise price of $6.25 and will expire five years from the date of issuance.

 

Common Stock Warrants:

If all the potential Common Stock Warrants outstanding at September 30, 2024, were exercised at the price of $5.00 per share, gross proceeds to us would be approximately $10.0 million and we would as a result issue an additional 2,000,000 shares of common stock.

 

Placement Agent Warrants:

If all the potential Placement Agent Warrants outstanding at September 30, 2024, were exercised at the price of $6.25 per share, gross proceeds to us would be approximately $0.5 million and we would as a result issue an additional 80,000 shares of common stock.

 

40

 

January 14, 2022, was the record date with respect to the distribution of five-year listed warrants (the “Series A Warrants”).  The Series A Warrants and the shares of common stock issuable upon the exercise of the Series A Warrants were registered on a registration statement that was filed with the SEC and was declared effective January 21, 2022. The Series A Warrants commenced trading on the Nasdaq Capital Market under the symbol “SQFTW” on January 24, 2022 and were distributed on that date to persons who held shares of common stock and existing outstanding warrants as of the January 14, 2022 record date, or who acquired shares of common stock in the market following the record date, and who continued to hold such shares at the close of trading on January 21, 2022. The Series A Warrants give the holder the right to purchase one share of common stock at $7.00 per share, for a period of five years. Should warrant holders not exercise the Series A Warrants during that holding period, the Series A Warrants will automatically convert to 1/10 of a common share at expiration, rounded down to the nearest number of whole shares.

 

Series A Warrants:

If all the potential Series A Warrants outstanding at September 30, 2024, were exercised at the price of $7.00 per share, gross proceeds to us would be approximately $101.2 million and we would as a result issue an additional 14,450,069 shares of common stock.

 

Inflation

 

Leases generally provide for limited increases in rent as a result of fixed increases, increases in the consumer price index (typically subject to ceilings), or increases in the clients’ sales volumes. We expect that inflation will cause these lease provisions to result in rent increases over time. During times when inflation is greater than increases in rent, as provided for in the leases, rent increases may not keep up with the rate of inflation.

 

However, our use of net lease agreements tends to reduce our exposure to rising property expenses due to inflation because the client is responsible for property expenses. Inflation and increased costs may have an adverse impact on our clients if increases in their operating expenses exceed increases in revenue.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company, we are not required to provide disclosure pursuant to this item.  

 

ITEM 4. CONTROLS AND PROCEDURES

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure based closely on the definition of “disclosure controls and procedures” in Rule 13a-14(c). In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. In connection with the preparation and audit of the financial statements as of and for the fiscal year ended December 31, 2023, a material weakness was identified in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis. This material weakness primarily relates to a non-recuring significant transaction for income tax provision under ASC 740, Income Taxes, and comprises the following:

 

 

We lack a formal review and approval process in connection with the annual income tax provision, specifically related to REIT and non-REIT subsidiaries and the ownership of Conduit shares received by the Company in the de-SPAC transaction on September 22, 2023.

 

 

We did not design adequate internal controls under an appropriate financial reporting framework, including monitoring controls and certain entity level controls with regards to the income tax provision.

 

41

 

If this material weakness is not remediated, it could result in a misstatement of account balances or disclosures that would result in a material misstatement to the annual or interim financial statements that would not be prevented or detected. We are implementing measures designed to improve our internal control over financial reporting to remediate this material weakness, although they have not been fully remediated as of the date of this filing.

 

The material weakness will not be considered remediated until our remediation plan has been fully implemented, the applicable controls operate for a sufficient period of time, and we have concluded, through testing, that the newly implemented and enhanced controls are operating effectively. We commenced the remediation plan and will be documenting and implementing such plan, followed with testing such controls over time. We cannot predict the success of such efforts or the outcome of its assessment of the remediation efforts. Our efforts may not remediate this material weakness in our internal control over financial reporting, or additional material weaknesses may be identified in the future. A failure to implement and maintain effective internal control over financial reporting could result in errors in our financial statements that could result in a restatement of our financial statements and could cause us to fail to meet our reporting obligations, any of which could diminish investor confidence in us and cause a decline in the price of our common stock.

 

Changes in Internal Control over Financial Reporting

 

We are adding controls around the calculation and preparation of income tax provisions and expenses, we are engaging with third party experts, and will continually identify and monitor the taxable status of each subsidiary for annual reporting.  There were no additional changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Furthermore, we do not believe that these controls have been impacted by COVID-19 related circumstances, including remote work arrangements with our employees.

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

None.

 

Item 1A. Risk Factors

 

None.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Stock Repurchase Program. While we will continue to pursue value creating investments, the Board of Directors believes there is significant embedded value in our assets that is yet to be realized by the market. Therefore, returning capital to stockholders through a repurchase program is an attractive use of capital currently. On September 15, 2022, the Board of Directors authorized a stock repurchase program of up to $6.0 million of outstanding shares of our Series A Common Stock and up to $4.0 million of our Series D Preferred Stock, which expired in September 2023. In November 2023, the Board of Directors authorized a stock repurchase program of up to $6.0 million of outstanding shares of our Series A Common Stock and up to $4.0 million of our Series D Preferred Stock which shall expire in November 2024. During the year ended December 31, 2023, the Company repurchased 23,041 shares of our Series D Preferred Stock at an average price of approximately $16.06 per share, including a commission of $0.035 per share, and no shares of our Series A Common Stock, for a total cost of $0.4 million for the Series D Preferred Stock. During the nine months ended September 30, 2024, we repurchased 137,709 shares of our Series A Common Stock, for a total cost of $97,394, with an average price of approximately $0.7072 per share. There were no repurchases of Series D Preferred Stock during the nine months ended September 30, 2024. Any repurchased shares are treated as authorized and unissued in accordance with Maryland law and shown as a reduction of stockholders’ equity at cost. The repurchased shares will be treated as authorized and unissued in accordance with Maryland law and shown as a reduction of stockholders' equity at cost. The following table contains information for shares of common stock repurchased during the nine months ended September 30, 2024.

 

42

 

Stock repurchases for Series A Common Stock.

 

Month

 

Total Number of Shares Purchased

   

Average Price Paid Per Share

   

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs

   

Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs

 

January 2024

        $           $ 6,000,000  

February 2024

                      6,000,000  

March 2024

                      6,000,000  

April 2024

                      6,000,000  

May 2024

                      6,000,000  

June 2024

    10,446       0.729       10,446       5,992,387  

July 2024

                      5,992,387  

August 2024

    44,190       0.679       44,190       5,962,369  

September 2024

    83,073       0.719       83,073       5,902,606  

Total

    137,709     $ 0.707       137,709     $ 5,902,606  

 

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures

 

None. 

 

Item 5. Other Information.

 

None.

 

 

43

 

Item 6. Exhibits.

 

Exhibit
Number

 

Description

31.1

 

Certificate of the Company's Chief Executive Officer (Principal Executive Officer) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant's Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2024.

31.2

 

Certification of the Company's Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant's Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2024.

32.1

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

101.INS

Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

   

101.SCH

Inline XBRL Taxonomy Extension Schema Document

   

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

   

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

   

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

   

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

   
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

44

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 19, 2024

Presidio Property Trust, Inc.

     
 

By:

/s/ Jack K. Heilbron

 

Name:

Jack K. Heilbron

 

Title:

Chief Executive Officer

     
 

By:

/s/ Ed Bentzen
 

Name:

Ed Bentzen
 

Title:

Chief Financial Officer

     
     
     
     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

45